###begin article-title 0
###xml 101 103 91 93 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 119 124 <span type="species:ncbi:9606">human</span>
Protein kinase C alpha and epsilon phosphorylation of troponin and myosin binding protein C reduce Ca2+ sensitivity in human myocardium
###end article-title 0
###begin p 1
###xml 395 397 385 387 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 534 536 514 516 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 584 586 560 562 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 875 877 849 851 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1467 1469 1429 1431 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1550 1552 1508 1510 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1574 1576 1528 1530 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1795 1797 1737 1739 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 332 337 <span type="species:ncbi:9606">human</span>
###xml 451 456 <span type="species:ncbi:9606">human</span>
###xml 1873 1878 <span type="species:ncbi:9606">human</span>
Previous studies indicated that the increase in protein kinase C (PKC)-mediated myofilament protein phosphorylation observed in failing myocardium might be detrimental for contractile function. This study was designed to reveal and compare the effects of PKCalpha- and PKCepsilon-mediated phosphorylation on myofilament function in human myocardium. Isometric force was measured at different [Ca2+] in single permeabilized cardiomyocytes from failing human left ventricular tissue. Activated PKCalpha and PKCepsilon equally reduced Ca2+ sensitivity in failing cardiomyocytes (DeltapCa50 = 0.08 +/- 0.01). Both PKC isoforms increased phosphorylation of troponin I- (cTnI) and myosin binding protein C (cMyBP-C) in failing cardiomyocytes. Subsequent incubation of failing cardiomyocytes with the catalytic subunit of protein kinase A (PKA) resulted in a further reduction in Ca2+ sensitivity, indicating that the effects of both PKC isoforms were not caused by cross-phosphorylation of PKA sites. Both isozymes showed no effects on maximal force and only PKCalpha resulted in a modest significant reduction in passive force. Effects of PKCalpha were only minor in donor cardiomyocytes, presumably because of already saturated cTnI and cMyBP-C phosphorylation levels. Donor tissue could therefore be used as a tool to reveal the functional effects of troponin T (cTnT) phosphorylation by PKCalpha. Massive dephosphorylation of cTnT with alkaline phosphatase increased Ca2+ sensitivity. Subsequently, PKCalpha treatment of donor cardiomyocytes reduced Ca2+ sensitivity (DeltapCa50 = 0.08 +/- 0.02) and solely increased phosphorylation of cTnT, but did not affect maximal and passive force. PKCalpha- and PKCepsilon-mediated phosphorylation of cMyBP-C and cTnI as well as cTnT decrease myofilament Ca2+ sensitivity and may thereby reduce contractility and enhance relaxation of human myocardium.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 117 119 117 119 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 190 192 190 192 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 235 236 231 232 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 350 351 342 343 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 353 355 345 347 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 357 359 349 351 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 492 494 480 482 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 611 612 595 596 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 614 616 598 600 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 644 646 622 624 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 750 752 728 730 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 754 756 732 734 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 758 760 736 738 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 885 887 857 859 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 889 891 861 863 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">40</xref>
###xml 1020 1022 986 988 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 137 142 <span type="species:ncbi:9606">human</span>
###xml 904 919 <span type="species:ncbi:10090">transgenic mice</span>
The protein kinase C (PKC) family consists of a number of different isozymes with different substrate specificities [16]. In the failing human heart PKC activity and the expression of the Ca2+ dependent isoform PKCalpha are increased [6]. PKCalpha has been shown to play an important role in the development of cardiac hypertrophy and heart failure [7, 12, 13]. PKCalpha directly phosphorylates regulatory myofilament proteins such as cardiac troponin I (cTnI) and cardiac troponin T (cTnT) [17]. PKCalpha also phosphorylates protein phosphatase inhibitor 1, which alters the activity of protein phosphatase 1 [7, 31]. PKCepsilon is another (Ca2+ independent) PKC isoform, which translocates upon activation to the myofilaments (and the sarcolemma) [10, 15, 16]. Several myofilament regulatory proteins [myosin binding protein C (cMyBP-C), cTnT, cTnI] serve as targets for PKCepsilon [24, 40]. Moreover, transgenic mice overexpressing constitutively active PKCepsilon slowly develop dilated cardiomyopathy with failure [11].
###end p 4
###begin p 5
###xml 86 88 86 88 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 192 193 192 193 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 195 197 195 197 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 199 201 199 201 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 203 205 203 205 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 387 389 387 389 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 718 720 710 712 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 734 735 726 727 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 318 323 <span type="species:ncbi:9606">human</span>
Studies in rodent myocardium indicated that cTnT and cTnI phosphorylation influence Ca2+ sensitivity and were involved in the PKC-mediated depression of the maximal force generating capacity [8, 18, 32, 33]. Using an in vitro motility assay, an association was observed between the increased PKC expression in failing human hearts and a reduction of the force exerted on thin filaments [29]. Moreover, a recent study using two different animal models of congestive heart failure, in which PKCalpha expression and activation was considerably increased, provided evidence that augmented PKCalpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction by a reduction of maximum force and of Ca2+ sensitivity [2].
###end p 5
###begin p 6
###xml 153 154 153 154 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 156 158 156 158 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 279 281 279 281 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 111 117 <span type="species:ncbi:9606">humans</span>
###xml 416 421 <span type="species:ncbi:9606">human</span>
###xml 513 518 <span type="species:ncbi:9606">human</span>
The expression of the different PKC isoforms, with different substrate specificity, varies between rodents and humans and with different disease states [1, 19]. This may affect the basal phosphorylation status of the myocardium and thus influence the effects of the kinases on Ca2+ sensitivity and force development per se. Specific information on the impact of the different PKC isoforms on contractile function in human myocardium is lacking. Therefore, we investigated the impact of PKCalpha and PKCepsilon in human tissue from donor and end-stage failing hearts obtained during transplant surgery.
###end p 6
###begin title 7
Materials and methods
###end title 7
###begin title 8
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human ventricular tissue
###end title 8
###begin p 9
###xml 206 207 206 207 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 639 646 639 646 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 646 686 646 686 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="10">Characteristics from donors and patients</p>
###xml 646 686 646 686 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="10">Characteristics from donors and patients</p></caption>
###xml 686 686 686 686 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 686 689 686 689 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Sex</th>
###xml 689 692 689 692 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Age</th>
###xml 692 700 692 700 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LVEF (%)</th>
###xml 700 710 700 710 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Medication</th>
###xml 686 710 686 710 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left">Sex</th><th align="left">Age</th><th align="left">LVEF (%)</th><th align="left">Medication</th></tr>
###xml 686 710 686 710 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left"/><th align="left">Sex</th><th align="left">Age</th><th align="left">LVEF (%)</th><th align="left">Medication</th></tr></thead>
###xml 710 717 710 717 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Donor 1</td>
###xml 717 723 717 723 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Female</td>
###xml 723 725 723 725 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">24</td>
###xml 725 726 725 726 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 726 727 726 727 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 710 727 710 727 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Donor 1</td><td align="left">Female</td><td char="." align="char">24</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr>
###xml 727 734 727 734 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Donor 2</td>
###xml 734 738 734 738 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 738 740 738 740 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">13</td>
###xml 740 741 740 741 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 741 742 741 742 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 727 742 727 742 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Donor 2</td><td align="left">Male</td><td char="." align="char">13</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr>
###xml 742 749 742 749 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Donor 3</td>
###xml 749 753 749 753 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 753 755 753 755 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">21</td>
###xml 755 756 755 756 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 756 757 756 757 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 742 757 742 757 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Donor 3</td><td align="left">Male</td><td char="." align="char">21</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr>
###xml 757 764 757 764 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Donor 4</td>
###xml 764 770 764 770 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Female</td>
###xml 770 772 770 772 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">38</td>
###xml 772 773 772 773 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 773 774 773 774 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 757 774 757 774 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Donor 4</td><td align="left">Female</td><td char="." align="char">38</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr>
###xml 774 783 774 783 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Patient 1</td>
###xml 783 789 783 789 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Female</td>
###xml 789 791 789 791 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">41</td>
###xml 791 792 791 792 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 792 801 792 801 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ACEI, Diu</td>
###xml 774 801 774 801 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Patient 1</td><td align="left">Female</td><td char="." align="char">41</td><td char="." align="char">&#8211;</td><td align="left">ACEI, Diu</td></tr>
###xml 801 810 801 810 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Patient 2</td>
###xml 810 816 810 816 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Female</td>
###xml 816 818 816 818 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">45</td>
###xml 818 819 818 819 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8</td>
###xml 819 834 819 831 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ACEI, Diu, &#946;</td>
###xml 801 834 801 831 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Patient 2</td><td align="left">Female</td><td char="." align="char">45</td><td char="." align="char">8</td><td align="left">ACEI, Diu, &#946;</td></tr>
###xml 834 843 831 840 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Patient 3</td>
###xml 843 847 840 844 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 847 849 844 846 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">65</td>
###xml 849 850 846 847 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 850 858 847 855 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ACEI,Diu</td>
###xml 834 858 831 855 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Patient 3</td><td align="left">Male</td><td char="." align="char">65</td><td char="." align="char">&#8211;</td><td align="left">ACEI,Diu</td></tr>
###xml 858 867 855 864 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Patient 4</td>
###xml 867 871 864 868 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 871 873 868 870 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">61</td>
###xml 873 875 870 872 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">12</td>
###xml 875 896 872 890 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ACEI, Amio, Diu, &#946;</td>
###xml 858 896 855 890 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Patient 4</td><td align="left">Male</td><td char="." align="char">61</td><td char="." align="char">12</td><td align="left">ACEI, Amio, Diu, &#946;</td></tr>
###xml 896 905 890 899 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Patient 5</td>
###xml 905 909 899 903 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 909 911 903 905 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">55</td>
###xml 911 913 905 907 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">15</td>
###xml 913 922 907 916 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ACEI, Diu</td>
###xml 896 922 890 916 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Patient 5</td><td align="left">Male</td><td char="." align="char">55</td><td char="." align="char">15</td><td align="left">ACEI, Diu</td></tr>
###xml 922 931 916 925 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Patient 6</td>
###xml 931 935 925 929 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 935 937 929 931 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">56</td>
###xml 937 939 931 933 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">15</td>
###xml 939 954 933 945 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ACEI, Diu, &#946;</td>
###xml 922 954 916 945 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Patient 6</td><td align="left">Male</td><td char="." align="char">56</td><td char="." align="char">15</td><td align="left">ACEI, Diu, &#946;</td></tr>
###xml 954 963 945 954 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Patient 7</td>
###xml 963 967 954 958 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 967 969 958 960 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">56</td>
###xml 969 971 960 962 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">20</td>
###xml 971 984 962 972 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ACEI,Diu,&#946;</td>
###xml 954 984 945 972 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Patient 7</td><td align="left">Male</td><td char="." align="char">56</td><td char="." align="char">20</td><td align="left">ACEI,Diu,&#946;</td></tr>
###xml 984 993 972 981 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Patient 8</td>
###xml 993 997 981 985 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 997 999 985 987 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">27</td>
###xml 999 1000 987 988 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8211;</td>
###xml 1000 1009 988 997 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ATII, Diu</td>
###xml 984 1009 972 997 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Patient 8</td><td align="left">Male</td><td char="." align="char">27</td><td char="." align="char">&#8211;</td><td align="left">ATII, Diu</td></tr>
###xml 1009 1018 997 1006 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Patient 9</td>
###xml 1018 1024 1006 1012 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Female</td>
###xml 1024 1026 1012 1014 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">23</td>
###xml 1026 1028 1014 1016 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">15</td>
###xml 1028 1043 1016 1028 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ACEI, Diu, &#946;</td>
###xml 1009 1043 997 1028 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Patient 9</td><td align="left">Female</td><td char="." align="char">23</td><td char="." align="char">15</td><td align="left">ACEI, Diu, &#946;</td></tr>
###xml 1043 1053 1028 1038 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Patient 10</td>
###xml 1053 1059 1038 1044 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Female</td>
###xml 1059 1061 1044 1046 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">65</td>
###xml 1061 1063 1046 1048 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">14</td>
###xml 1063 1072 1048 1057 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ACEI, Diu</td>
###xml 1043 1072 1028 1057 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Patient 10</td><td align="left">Female</td><td char="." align="char">65</td><td char="." align="char">14</td><td align="left">ACEI, Diu</td></tr>
###xml 710 1072 710 1057 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Donor 1</td><td align="left">Female</td><td char="." align="char">24</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Donor 2</td><td align="left">Male</td><td char="." align="char">13</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Donor 3</td><td align="left">Male</td><td char="." align="char">21</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Donor 4</td><td align="left">Female</td><td char="." align="char">38</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Patient 1</td><td align="left">Female</td><td char="." align="char">41</td><td char="." align="char">&#8211;</td><td align="left">ACEI, Diu</td></tr><tr><td align="left">Patient 2</td><td align="left">Female</td><td char="." align="char">45</td><td char="." align="char">8</td><td align="left">ACEI, Diu, &#946;</td></tr><tr><td align="left">Patient 3</td><td align="left">Male</td><td char="." align="char">65</td><td char="." align="char">&#8211;</td><td align="left">ACEI,Diu</td></tr><tr><td align="left">Patient 4</td><td align="left">Male</td><td char="." align="char">61</td><td char="." align="char">12</td><td align="left">ACEI, Amio, Diu, &#946;</td></tr><tr><td align="left">Patient 5</td><td align="left">Male</td><td char="." align="char">55</td><td char="." align="char">15</td><td align="left">ACEI, Diu</td></tr><tr><td align="left">Patient 6</td><td align="left">Male</td><td char="." align="char">56</td><td char="." align="char">15</td><td align="left">ACEI, Diu, &#946;</td></tr><tr><td align="left">Patient 7</td><td align="left">Male</td><td char="." align="char">56</td><td char="." align="char">20</td><td align="left">ACEI,Diu,&#946;</td></tr><tr><td align="left">Patient 8</td><td align="left">Male</td><td char="." align="char">27</td><td char="." align="char">&#8211;</td><td align="left">ATII, Diu</td></tr><tr><td align="left">Patient 9</td><td align="left">Female</td><td char="." align="char">23</td><td char="." align="char">15</td><td align="left">ACEI, Diu, &#946;</td></tr><tr><td align="left">Patient 10</td><td align="left">Female</td><td char="." align="char">65</td><td char="." align="char">14</td><td align="left">ACEI, Diu</td></tr></tbody>
###xml 686 1072 686 1057 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Sex</th><th align="left">Age</th><th align="left">LVEF (%)</th><th align="left">Medication</th></tr></thead><tbody><tr><td align="left">Donor 1</td><td align="left">Female</td><td char="." align="char">24</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Donor 2</td><td align="left">Male</td><td char="." align="char">13</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Donor 3</td><td align="left">Male</td><td char="." align="char">21</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Donor 4</td><td align="left">Female</td><td char="." align="char">38</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Patient 1</td><td align="left">Female</td><td char="." align="char">41</td><td char="." align="char">&#8211;</td><td align="left">ACEI, Diu</td></tr><tr><td align="left">Patient 2</td><td align="left">Female</td><td char="." align="char">45</td><td char="." align="char">8</td><td align="left">ACEI, Diu, &#946;</td></tr><tr><td align="left">Patient 3</td><td align="left">Male</td><td char="." align="char">65</td><td char="." align="char">&#8211;</td><td align="left">ACEI,Diu</td></tr><tr><td align="left">Patient 4</td><td align="left">Male</td><td char="." align="char">61</td><td char="." align="char">12</td><td align="left">ACEI, Amio, Diu, &#946;</td></tr><tr><td align="left">Patient 5</td><td align="left">Male</td><td char="." align="char">55</td><td char="." align="char">15</td><td align="left">ACEI, Diu</td></tr><tr><td align="left">Patient 6</td><td align="left">Male</td><td char="." align="char">56</td><td char="." align="char">15</td><td align="left">ACEI, Diu, &#946;</td></tr><tr><td align="left">Patient 7</td><td align="left">Male</td><td char="." align="char">56</td><td char="." align="char">20</td><td align="left">ACEI,Diu,&#946;</td></tr><tr><td align="left">Patient 8</td><td align="left">Male</td><td char="." align="char">27</td><td char="." align="char">&#8211;</td><td align="left">ATII, Diu</td></tr><tr><td align="left">Patient 9</td><td align="left">Female</td><td char="." align="char">23</td><td char="." align="char">15</td><td align="left">ACEI, Diu, &#946;</td></tr><tr><td align="left">Patient 10</td><td align="left">Female</td><td char="." align="char">65</td><td char="." align="char">14</td><td align="left">ACEI, Diu</td></tr></tbody></table>
###xml 1072 1076 1057 1061 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">LVEF</italic>
###xml 1113 1117 1098 1102 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ACEI</italic>
###xml 1160 1164 1145 1149 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ATII</italic>
###xml 1201 1205 1186 1190 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Amio</italic>
###xml 1218 1221 1203 1206 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Diu</italic>
###xml 1233 1237 1218 1219 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 1072 1250 1057 1232 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="11"><italic>LVEF</italic> left ventricular ejection fraction, <italic>ACEI</italic> angiotensin-converting-enzyme inhibitors, <italic>ATII</italic> angiotensin II receptor antagonist, <italic>Amio</italic> amiodarone, <italic>Diu</italic> diuretics, <italic>&#946;</italic> beta-blocker</p>
###xml 1072 1250 1057 1232 <table-wrap-foot xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="11"><italic>LVEF</italic> left ventricular ejection fraction, <italic>ACEI</italic> angiotensin-converting-enzyme inhibitors, <italic>ATII</italic> angiotensin II receptor antagonist, <italic>Amio</italic> amiodarone, <italic>Diu</italic> diuretics, <italic>&#946;</italic> beta-blocker</p></table-wrap-foot>
###xml 639 1250 639 1232 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="10">Characteristics from donors and patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Sex</th><th align="left">Age</th><th align="left">LVEF (%)</th><th align="left">Medication</th></tr></thead><tbody><tr><td align="left">Donor 1</td><td align="left">Female</td><td char="." align="char">24</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Donor 2</td><td align="left">Male</td><td char="." align="char">13</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Donor 3</td><td align="left">Male</td><td char="." align="char">21</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Donor 4</td><td align="left">Female</td><td char="." align="char">38</td><td char="." align="char">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Patient 1</td><td align="left">Female</td><td char="." align="char">41</td><td char="." align="char">&#8211;</td><td align="left">ACEI, Diu</td></tr><tr><td align="left">Patient 2</td><td align="left">Female</td><td char="." align="char">45</td><td char="." align="char">8</td><td align="left">ACEI, Diu, &#946;</td></tr><tr><td align="left">Patient 3</td><td align="left">Male</td><td char="." align="char">65</td><td char="." align="char">&#8211;</td><td align="left">ACEI,Diu</td></tr><tr><td align="left">Patient 4</td><td align="left">Male</td><td char="." align="char">61</td><td char="." align="char">12</td><td align="left">ACEI, Amio, Diu, &#946;</td></tr><tr><td align="left">Patient 5</td><td align="left">Male</td><td char="." align="char">55</td><td char="." align="char">15</td><td align="left">ACEI, Diu</td></tr><tr><td align="left">Patient 6</td><td align="left">Male</td><td char="." align="char">56</td><td char="." align="char">15</td><td align="left">ACEI, Diu, &#946;</td></tr><tr><td align="left">Patient 7</td><td align="left">Male</td><td char="." align="char">56</td><td char="." align="char">20</td><td align="left">ACEI,Diu,&#946;</td></tr><tr><td align="left">Patient 8</td><td align="left">Male</td><td char="." align="char">27</td><td char="." align="char">&#8211;</td><td align="left">ATII, Diu</td></tr><tr><td align="left">Patient 9</td><td align="left">Female</td><td char="." align="char">23</td><td char="." align="char">15</td><td align="left">ACEI, Diu, &#946;</td></tr><tr><td align="left">Patient 10</td><td align="left">Female</td><td char="." align="char">65</td><td char="." align="char">14</td><td align="left">ACEI, Diu</td></tr></tbody></table><table-wrap-foot><p textid="11"><italic>LVEF</italic> left ventricular ejection fraction, <italic>ACEI</italic> angiotensin-converting-enzyme inhibitors, <italic>ATII</italic> angiotensin II receptor antagonist, <italic>Amio</italic> amiodarone, <italic>Diu</italic> diuretics, <italic>&#946;</italic> beta-blocker</p></table-wrap-foot></table-wrap>
###xml 108 116 <span type="species:ncbi:9606">patients</span>
###xml 408 413 <span type="species:ncbi:9606">Human</span>
###xml 492 497 <span type="species:ncbi:9606">Human</span>
###xml 774 781 <span type="species:ncbi:9606">Patient</span>
Left ventricular (LV) transmural tissue samples were obtained during heart transplantation surgery from ten patients with end-stage dilated cardiomyopathy (NYHA IV) and four non-failing donor hearts (Table 1). The tissue was collected in cardioplegic solution and stored in liquid nitrogen. Samples were obtained after informed consent and with approval of the local Ethical Committee (St Vincents' Hospital Human Research Ethics Committee: File number: H03/118; Title: Molecular Analysis of Human heart Failure). The investigation conforms with the principles outlined in the Declaration of Helsinki (Cardiovascular Research 1997;35:2-4).Table 1Characteristics from donors and patientsSexAgeLVEF (%)MedicationDonor 1Female24--Donor 2Male13--Donor 3Male21--Donor 4Female38--Patient 1Female41-ACEI, DiuPatient 2Female458ACEI, Diu, betaPatient 3Male65-ACEI,DiuPatient 4Male6112ACEI, Amio, Diu, betaPatient 5Male5515ACEI, DiuPatient 6Male5615ACEI, Diu, betaPatient 7Male5620ACEI,Diu,betaPatient 8Male27-ATII, DiuPatient 9Female2315ACEI, Diu, betaPatient 10Female6514ACEI, DiuLVEF left ventricular ejection fraction, ACEI angiotensin-converting-enzyme inhibitors, ATII angiotensin II receptor antagonist, Amio amiodarone, Diu diuretics, beta beta-blocker
###end p 9
###begin p 10
###xml 32 40 <span type="species:ncbi:9606">patients</span>
Characteristics from donors and patients
###end p 10
###begin p 11
###xml 0 4 0 4 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">LVEF</italic>
###xml 41 45 41 45 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ACEI</italic>
###xml 88 92 88 92 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ATII</italic>
###xml 129 133 129 133 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Amio</italic>
###xml 146 149 146 149 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Diu</italic>
###xml 161 165 161 162 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
LVEF left ventricular ejection fraction, ACEI angiotensin-converting-enzyme inhibitors, ATII angiotensin II receptor antagonist, Amio amiodarone, Diu diuretics, beta beta-blocker
###end p 11
###begin title 12
Force measurements
###end title 12
###begin p 13
###xml 255 257 254 256 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 259 261 258 260 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 262 264 261 263 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
Cardiomyocytes were mechanically isolated, Triton X-100 permeabilized and mounted in the experimental set-up at a sarcomere length of 2.2 mum. Force measurements and maximal rate of force redevelopment measurements were performed as described previously [28, 35-37].
###end p 13
###begin p 14
###xml 167 168 167 168 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 185 186 185 186 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 424 425 418 419 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 442 443 436 437 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 931 932 919 920 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 932 934 920 922 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">tr</sub>
###xml 965 967 953 955 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1046 1048 1034 1036 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1199 1201 1187 1189 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1319 1321 1307 1309 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1375 1377 1363 1365 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">38</xref>
###xml 289 294 <span type="species:ncbi:42554">tetra</span>
Briefly, a single cardiomyocyte was mounted between a force transducer and piezoelectric motor. After transferring the cardiomyocyte from relaxing solution (5.89 mM Na2ATP, 6.48 mM MgCl2, 40.76 mM propionic acid (Kprop), 100 mM Bis-2-aminoethanesulfonic acid (BES), 7.0 mM ethylene glycol tetra acetic acid (EGTA), 14.5 mM phosphocreatine disodium salt (CrP), pH 7.10 at 15degreesC, pCa 9) to activating solution (5.97 mM Na2ATP, 6.28 mM MgCl2, 40.64 mM Kprop, 100 mM BES, 7.0 mM CaEGTA, 14.5 mM CrP, pH 7.10 at 15degreesC, pCa 4.5), isometric force was measured. After reaching steady force, the cardiomyocyte was 20% reduced in length within 2 ms and restretched after 30 ms (slack test). During this slack test, force first dropped to zero and after the restretch quickly redeveloped to the original steady state level. A single exponential was fitted to estimate the rate constant of force redevelopment at maximal activation (Ktr-max). Calcium sensitivity (pCa50) was determined by measuring force in activating solutions with submaximal [Ca2+] (pCa values ranged from 5.0 to 6.0) obtained by appropriate mixing of the activating and relaxing solutions. The initial control force at maximal [Ca2+] (i.e., pCa 4.5) was used to calculate the maximal force per cross-sectional area. The force values at submaximal [Ca2+] were normalized to the interpolated control values [38].
###end p 14
###begin p 15
###xml 94 96 88 90 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 295 300 <span type="species:ncbi:9606">human</span>
###xml 364 369 <span type="species:ncbi:9606">human</span>
After the initial force-pCa series, the myocyte was incubated for 60 min at 20degreesC in a Ca2+-containing solution (pCa 5.9) containing 6 mM dithiothreitol (DTT), 1 muM PMA (phorbol 12-myristate 13-acetate; Sigma), 50 nM calyculin A (calA, Sigma) without kinase (time control), with 10 mug/mL human recombinant PKCalpha (Sigma P1782; batch 93K0330) or 10 mug/mL human recombinant PKCepsilon (Sigma P1164; batch 060K1890). CalA was added to the incubation buffer to prevent protein dephosphorylation during incubation. The concentrations of the active PKC isoforms were saturating as no further effect on cardiomyocyte function were seen when the concentration was doubled. A separate group of failing myocytes was incubated for 40 min at 20degreesC in relaxing solution (see above) containing 6 mM DTT and 100 U/mL of the catalytic subunit of protein kinase A (PKA, Sigma P2645; batch 35H9522). After the incubation the force-pCa series was repeated. A third force-pCa series was performed to study sequential effects, i.e., PKC isoforms after PKA or visa versa.
###end p 15
###begin p 16
###xml 130 134 <span type="species:ncbi:9913">calf</span>
The effect of PKCalpha was also investigated upon pretreatment of failing and donor cardiomyocytes with alkaline phosphatase (AP, calf intestinal, New England Biolabs; 2,000 U/mL) in relaxing solution (pCa 9) containing 6 mM DTT and 50 muL/mL protease inhibitor cocktail (PIC, Sigma, P8340) for 60 min at 20degreesC. All force measurements were performed at 15degreesC.
###end p 16
###begin title 17
Protein analysis
###end title 17
###begin title 18
Endogenous protein phosphorylation
###end title 18
###begin p 19
###xml 260 262 254 256 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 629 630 597 598 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1363 1365 1328 1330 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR43">43</xref>
To preserve the endogenous phosphorylation status, frozen tissue samples (~1 mg dry weight) were homogenized in liquid nitrogen and resuspended in 1 mL cold (-20degreesC) 10% trichloroacetic acid solution (TCA; dissolved in acetone containing 0.1% (w/v) DTT) [27]. Tissue homogenates were kept for 1 h at -80degreesC and slowly heated to room temperature by stepwise increments in temperature as follows: 20 min at -20degreesC, 20 min at 4degreesC and 20 min at room temperature (20 +/- 2degreesC). The homogenates were thoroughly mixed on a vortex between all steps. Thereafter, the tissue homogenates were centrifuged at 12,000g for 15 min and tissue pellets were washed with 1 mL of 0.2% (w/v) DTT-acetone solution and shaken for 5 min at room temperature. Centrifugation, washing and shaking was repeated three times. Thereafter tissue pellets were freeze-dried and homogenized in 1D-sample buffer containing 15% glycerol, 62.5 mM Tris (pH 6.8), 1% (w/v) SDS and 2% (w/v) DTT (final concentration 2.5 mug dry weight/muL). To determine basal phosphorylation status of myofilament proteins, myocardial samples (TCA treated 20 mug/lane) were separated on gradient gels (Criterion Tris-HCl 4-15% gel, BioRad) and stained with Pro-Q diamond phosphoprotein gel stain (Pro-Q; Molecular Probes) in conjunction with SYPRO Ruby staining (Molecular Probes) of the gels [43]. The phosphorylation signals for myofilament proteins were normalized to the intensities of the SYPRO Ruby-stained myosin binding protein C (cMyBP-C) bands. All signals were quantified using the luminescent image analyzer LAS-3000 (Fuji Science Imaging Systems) and Aida image analyzer software (Isotopenmebetagerate GmbH, Staubenhardt, Germany).
###end p 19
###begin title 20
Alterations in myofilament protein phosphorylation
###end title 20
###begin p 21
To investigate the effect of the PKC isoforms as well as of PKA and AP on myofilament protein phosphorylation 600 mug (dry weight) of tissue was treated in with Triton X-100 (0.5%) in relaxing solution (pCa 9) containing PIC (5 muL/mL), phosphatase inhibitor cocktail (PhIC2, Sigma, P5726, 5 muL/mL) and calA (50 nM) for 5 min at room temperature, washed twice with relaxing solution without Triton X-100 and subsequently incubated for 60 min (or 40 min for PKA) at 20degreesC in 100 muL of (1) relaxing solution containing PIC (50 muL/mL), PhIC2 (50 muL/mL), calA (50 nM) and DTT (6 mM)(=control incubation); (2) activating solution (pCa 5.9) containing PIC (50 muL/mL), PhIC2 (50 muL/mL), calA (50 nM), DTT (6 mM), PMA (1 muM) and PKCalpha (10 mug/mL) or (3) PKCepsilon (10 mug/mL); (4) relaxing solution containing PIC (50 muL/mL), PhIC2 (50 muL/mL), calA (50 nM), DTT (6 mML) and PKA (100 U/mL); (5) relaxing solution containing PIC (50 muL/mL), DTT (6 mM) and AP (2,000 U/mL). Part of the tissue treated with AP was washed and subsequently incubated with PKCalpha (see incubation no. 2). Subsequently, tissue was treated with TCA and analyzed using ProQ-stained gradient gels as described above.
###end p 21
###begin p 22
###xml 588 589 575 576 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
To investigate the effect of PKCalpha phosphorylation of titin, tissue samples with a final concentration of ~10 mug/muL dry weight were homogenized in 100-150 muL sample buffer consisting of 0.55 M Tris HCL, 0.55 M EDTA, 10% glycerol, 1% beta-mercaptoethanol, 20% (w/v) SDS, 8 muL/mL leupeptin (Peptin-institute, Japan), 10 muL/mL PhIC1 (Sigma, P2850) and PhIC2, pH6.8. Myocardial samples (~100 mug/lane) were separated on agarose strengthened 2% sodium dodecyl sulfate-polyacrylamide gels and stained with Pro-Q diamond phosphoprotein gel stain in conjunction with Sypro Ruby staining [5]. Staining and analysis as described above.
###end p 22
###begin title 23
Data analysis
###end title 23
###begin p 24
###xml 75 77 75 77 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 116 117 114 115 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 228 229 226 227 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 339 340 327 328 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 505 506 493 494 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Force-pCa relations were fit to the Hill equation as described previously [37]. Values are given as mean +/- SEM of n experiments. Cardiomyocyte force values for donor and failing samples were compared using an unpaired Student t test. Effects of incubations without or with PKCalpha, PKCepsilon, PKA or AP were tested with paired Student t test. Repeated measures ANOVA followed by a Bonferroni post hoc test was used when studying the effects of sequential incubations with the PKC isoforms, PKA or AP. P < 0.05 was considered significant.
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
###xml 71 73 61 63 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
PKCalpha and PKCepsilon phosphorylation of cTnI and cMyBP-C decrease Ca2+ sensitivity in failing myocardium
###end title 26
###begin p 27
###xml 97 98 93 94 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 136 137 126 127 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 186 188 176 178 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 205 207 195 197 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 215 216 205 206 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 273 274 263 264 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 274 277 264 267 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 295 296 285 286 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 296 299 286 289 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pas</sub>
###xml 387 388 367 368 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 388 391 368 371 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pas</sub>
###xml 399 400 379 380 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 404 405 384 385 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 405 408 385 388 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 410 411 390 391 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 411 414 391 394 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pas</sub>
###xml 422 424 402 404 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 481 482 461 462 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 593 594 573 574 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 597 603 577 583 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 678 680 648 650 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 718 720 688 690 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 833 834 799 800 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 842 843 808 809 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 861 862 821 822 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 869 870 829 830 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 925 927 881 883 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 978 980 934 936 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1013 1014 969 970 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1102 1103 1058 1059 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1322 1333 1268 1279 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Upper panel</italic>
###xml 1350 1361 1296 1307 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Lower panel</italic>
###xml 1377 1380 1323 1326 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MHC</italic>
###xml 1401 1403 1347 1349 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PM</italic>
###xml 1462 1463 1408 1409 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1624 1625 1566 1567 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1647 1648 1583 1584 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1835 1836 1771 1772 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1895 1896 1831 1832 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 603 1901 583 1837 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">Effect of PKC&#945; end &#949; phosphorylation of myofilament protein on Ca<sup>2+</sup> sensitivity in failing myocardium. Ca<sup>2+</sup> sensitivity of force was significantly decreased in failing cardiomyocytes after incubation with both PKC&#945; (<italic>n</italic>&#160;=&#160;14) (<bold>a</bold>) and PKC&#949; (<italic>n</italic>&#160;=&#160;7) (<bold>b</bold>). The shifts in the mid-points of the curves (&#916;pCa<sub>50</sub>) were very similar. Maximum force at saturating Ca<sup>2+</sup> concentration was not affected. <bold>c</bold> Sypro and ProQ stained 1D gels of failing tissue samples incubated without kinases (C) <bold>d</bold> Effect of incubation of PKC&#945; and PKC&#949; on phosphorylation of recombinant troponin complex in comparison to control incubation (C) and basal endogenous phosphorylation of cTnT and cTnI in a failing (F) sample. <italic>Upper panel</italic> Sypro staining. <italic>Lower panel</italic> ProQ staining. <italic>MHC</italic> myosin heavy chain, <italic>PM</italic> peppermintStick phosphoprotein marker (Molecular Probes). <bold>e</bold> Phosphorylation of myofilament proteins was expressed relative to the Sypro Ruby-stained cMyBP-C bands to correct for differences in protein loading. PKC&#945; (<italic>n</italic>&#160;=&#160;5) and PKC&#949; (<italic>n</italic>&#160;=&#160;2) both significantly increased phosphorylation of endogenous myosin binding protein C (cMyBP-C) and troponin I (cTnI), while effects on desmin and troponin T (cTnT) were only small. *<italic>P</italic>&#160;&lt;&#160;0.05, PKC treatment versus control incubation in paired <italic>t</italic> test</p>
###xml 603 1901 583 1837 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28">Effect of PKC&#945; end &#949; phosphorylation of myofilament protein on Ca<sup>2+</sup> sensitivity in failing myocardium. Ca<sup>2+</sup> sensitivity of force was significantly decreased in failing cardiomyocytes after incubation with both PKC&#945; (<italic>n</italic>&#160;=&#160;14) (<bold>a</bold>) and PKC&#949; (<italic>n</italic>&#160;=&#160;7) (<bold>b</bold>). The shifts in the mid-points of the curves (&#916;pCa<sub>50</sub>) were very similar. Maximum force at saturating Ca<sup>2+</sup> concentration was not affected. <bold>c</bold> Sypro and ProQ stained 1D gels of failing tissue samples incubated without kinases (C) <bold>d</bold> Effect of incubation of PKC&#945; and PKC&#949; on phosphorylation of recombinant troponin complex in comparison to control incubation (C) and basal endogenous phosphorylation of cTnT and cTnI in a failing (F) sample. <italic>Upper panel</italic> Sypro staining. <italic>Lower panel</italic> ProQ staining. <italic>MHC</italic> myosin heavy chain, <italic>PM</italic> peppermintStick phosphoprotein marker (Molecular Probes). <bold>e</bold> Phosphorylation of myofilament proteins was expressed relative to the Sypro Ruby-stained cMyBP-C bands to correct for differences in protein loading. PKC&#945; (<italic>n</italic>&#160;=&#160;5) and PKC&#949; (<italic>n</italic>&#160;=&#160;2) both significantly increased phosphorylation of endogenous myosin binding protein C (cMyBP-C) and troponin I (cTnI), while effects on desmin and troponin T (cTnT) were only small. *<italic>P</italic>&#160;&lt;&#160;0.05, PKC treatment versus control incubation in paired <italic>t</italic> test</p></caption>
###xml 1901 1901 1837 1837 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="395_2009_53_Fig1_HTML" id="MO1"/>
###xml 597 1901 577 1837 <fig xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="28">Effect of PKC&#945; end &#949; phosphorylation of myofilament protein on Ca<sup>2+</sup> sensitivity in failing myocardium. Ca<sup>2+</sup> sensitivity of force was significantly decreased in failing cardiomyocytes after incubation with both PKC&#945; (<italic>n</italic>&#160;=&#160;14) (<bold>a</bold>) and PKC&#949; (<italic>n</italic>&#160;=&#160;7) (<bold>b</bold>). The shifts in the mid-points of the curves (&#916;pCa<sub>50</sub>) were very similar. Maximum force at saturating Ca<sup>2+</sup> concentration was not affected. <bold>c</bold> Sypro and ProQ stained 1D gels of failing tissue samples incubated without kinases (C) <bold>d</bold> Effect of incubation of PKC&#945; and PKC&#949; on phosphorylation of recombinant troponin complex in comparison to control incubation (C) and basal endogenous phosphorylation of cTnT and cTnI in a failing (F) sample. <italic>Upper panel</italic> Sypro staining. <italic>Lower panel</italic> ProQ staining. <italic>MHC</italic> myosin heavy chain, <italic>PM</italic> peppermintStick phosphoprotein marker (Molecular Probes). <bold>e</bold> Phosphorylation of myofilament proteins was expressed relative to the Sypro Ruby-stained cMyBP-C bands to correct for differences in protein loading. PKC&#945; (<italic>n</italic>&#160;=&#160;5) and PKC&#949; (<italic>n</italic>&#160;=&#160;2) both significantly increased phosphorylation of endogenous myosin binding protein C (cMyBP-C) and troponin I (cTnI), while effects on desmin and troponin T (cTnT) were only small. *<italic>P</italic>&#160;&lt;&#160;0.05, PKC treatment versus control incubation in paired <italic>t</italic> test</p></caption><graphic xlink:href="395_2009_53_Fig1_HTML" id="MO1"/></fig>
###xml 1901 1908 1837 1844 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 1908 2028 1844 1950 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="29">Overview of the force measurements with PKC&#945;, PKC&#949; and PKA incubations (a) and AP and PKC&#945; incubations (b)</p>
###xml 1908 2028 1844 1950 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29">Overview of the force measurements with PKC&#945;, PKC&#949; and PKA incubations (a) and AP and PKC&#945; incubations (b)</p></caption>
###xml 2028 2038 1950 1960 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Incubation</th>
###xml 2038 2064 1960 1986 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">Cardiomyocyte measurements</th>
###xml 2028 2064 1950 1986 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2">Incubation</th><th align="left" colspan="5">Cardiomyocyte measurements</th></tr>
###xml 2064 2065 1986 1987 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 2065 2068 1987 1990 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 2064 2068 1986 1990 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>F</italic><sub>max</sub></th>
###xml 2068 2069 1990 1991 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 2069 2072 1991 1994 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pas</sub>
###xml 2068 2072 1990 1994 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>F</italic><sub>pas</sub></th>
###xml 2075 2077 1997 1999 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 2072 2077 1994 1999 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">pCa<sub>50</sub></th>
###xml 2077 2079 1999 2001 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">nH</th>
###xml 2079 2080 2001 2002 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 2080 2082 2002 2004 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">tr</sub>
###xml 2089 2091 2011 2013 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 2079 2092 2001 2014 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>K</italic><sub>tr</sub>-max (s<sup>&#8722;1</sup>)</th>
###xml 2064 2092 1986 2014 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"><italic>F</italic><sub>max</sub></th><th align="left"><italic>F</italic><sub>pas</sub></th><th align="left">pCa<sub>50</sub></th><th align="left">nH</th><th align="left"><italic>K</italic><sub>tr</sub>-max (s<sup>&#8722;1</sup>)</th></tr>
###xml 2028 2092 1950 2014 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2">Incubation</th><th align="left" colspan="5">Cardiomyocyte measurements</th></tr><tr><th align="left"><italic>F</italic><sub>max</sub></th><th align="left"><italic>F</italic><sub>pas</sub></th><th align="left">pCa<sub>50</sub></th><th align="left">nH</th><th align="left"><italic>K</italic><sub>tr</sub>-max (s<sup>&#8722;1</sup>)</th></tr></thead>
###xml 2092 2095 2014 2017 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6">(a)</td>
###xml 2092 2095 2014 2017 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6">(a)</td></tr>
###xml 2095 2103 2017 2021 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">PKC&#945;</td>
###xml 2103 2132 2021 2050 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">7 failing hearts; 14 myocytes</td>
###xml 2095 2132 2017 2050 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">PKC&#945;</td><td align="left" colspan="5">7 failing hearts; 14 myocytes</td></tr>
###xml 2132 2138 2050 2056 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Before</td>
###xml 2138 2150 2056 2066 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">28.2&#160;&#177;&#160;2.4</td>
###xml 2150 2161 2066 2075 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.5&#160;&#177;&#160;0.2</td>
###xml 2161 2174 2075 2086 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.67&#160;&#177;&#160;0.03</td>
###xml 2174 2187 2086 2097 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.43&#160;&#177;&#160;0.18</td>
###xml 2187 2200 2097 2108 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.69&#160;&#177;&#160;0.03</td>
###xml 2132 2200 2050 2108 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Before</td><td align="left">28.2&#160;&#177;&#160;2.4</td><td align="left">1.5&#160;&#177;&#160;0.2</td><td align="left">5.67&#160;&#177;&#160;0.03</td><td align="left">3.43&#160;&#177;&#160;0.18</td><td align="left">0.69&#160;&#177;&#160;0.03</td></tr>
###xml 2200 2205 2108 2113 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">After</td>
###xml 2205 2217 2113 2123 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">28.6&#160;&#177;&#160;2.4</td>
###xml 2217 2229 2123 2133 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.4&#160;&#177;&#160;0.2*</td>
###xml 2229 2243 2133 2145 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.59&#160;&#177;&#160;0.03*</td>
###xml 2243 2256 2145 2156 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.28&#160;&#177;&#160;0.24</td>
###xml 2256 2270 2156 2168 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.81&#160;&#177;&#160;0.04*</td>
###xml 2200 2270 2108 2168 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">After</td><td align="left">28.6&#160;&#177;&#160;2.4</td><td align="left">1.4&#160;&#177;&#160;0.2*</td><td align="left">5.59&#160;&#177;&#160;0.03*</td><td align="left">3.28&#160;&#177;&#160;0.24</td><td align="left">0.81&#160;&#177;&#160;0.04*</td></tr>
###xml 2270 2280 2168 2172 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">PKC&#949;</td>
###xml 2280 2308 2172 2200 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">5 failing hearts; 7 myocytes</td>
###xml 2270 2308 2168 2200 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">PKC&#949;</td><td align="left" colspan="5">5 failing hearts; 7 myocytes</td></tr>
###xml 2308 2314 2200 2206 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Before</td>
###xml 2314 2326 2206 2216 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">30.3&#160;&#177;&#160;3.9</td>
###xml 2326 2337 2216 2225 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.6&#160;&#177;&#160;0.3</td>
###xml 2337 2350 2225 2236 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.68&#160;&#177;&#160;0.03</td>
###xml 2350 2363 2236 2247 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.86&#160;&#177;&#160;0.20</td>
###xml 2363 2376 2247 2258 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.60&#160;&#177;&#160;0.05</td>
###xml 2308 2376 2200 2258 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Before</td><td align="left">30.3&#160;&#177;&#160;3.9</td><td align="left">1.6&#160;&#177;&#160;0.3</td><td align="left">5.68&#160;&#177;&#160;0.03</td><td align="left">3.86&#160;&#177;&#160;0.20</td><td align="left">0.60&#160;&#177;&#160;0.05</td></tr>
###xml 2376 2381 2258 2263 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">After</td>
###xml 2381 2393 2263 2273 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">31.2&#160;&#177;&#160;3.1</td>
###xml 2393 2404 2273 2282 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.4&#160;&#177;&#160;0.2</td>
###xml 2404 2418 2282 2294 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.60&#160;&#177;&#160;0.02*</td>
###xml 2418 2431 2294 2305 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.42&#160;&#177;&#160;0.13</td>
###xml 2431 2445 2305 2317 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.74&#160;&#177;&#160;0.05*</td>
###xml 2376 2445 2258 2317 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">After</td><td align="left">31.2&#160;&#177;&#160;3.1</td><td align="left">1.4&#160;&#177;&#160;0.2</td><td align="left">5.60&#160;&#177;&#160;0.02*</td><td align="left">3.42&#160;&#177;&#160;0.13</td><td align="left">0.74&#160;&#177;&#160;0.05*</td></tr>
###xml 2445 2448 2317 2320 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">PKA</td>
###xml 2448 2477 2320 2349 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">7 failing hearts; 14 myocytes</td>
###xml 2445 2477 2317 2349 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">PKA</td><td align="left" colspan="5">7 failing hearts; 14 myocytes</td></tr>
###xml 2477 2483 2349 2355 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Before</td>
###xml 2483 2495 2355 2365 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">22.8&#160;&#177;&#160;2.1</td>
###xml 2495 2506 2365 2374 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.4&#160;&#177;&#160;0.2</td>
###xml 2506 2519 2374 2385 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.65&#160;&#177;&#160;0.02</td>
###xml 2519 2532 2385 2396 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.34&#160;&#177;&#160;0.07</td>
###xml 2532 2545 2396 2407 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.68&#160;&#177;&#160;0.02</td>
###xml 2477 2545 2349 2407 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Before</td><td align="left">22.8&#160;&#177;&#160;2.1</td><td align="left">1.4&#160;&#177;&#160;0.2</td><td align="left">5.65&#160;&#177;&#160;0.02</td><td align="left">3.34&#160;&#177;&#160;0.07</td><td align="left">0.68&#160;&#177;&#160;0.02</td></tr>
###xml 2545 2550 2407 2412 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">After</td>
###xml 2550 2562 2412 2422 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">22.9&#160;&#177;&#160;2.0</td>
###xml 2562 2573 2422 2431 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.4&#160;&#177;&#160;0.1</td>
###xml 2573 2587 2431 2443 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.53&#160;&#177;&#160;0.01*</td>
###xml 2587 2601 2443 2455 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.57&#160;&#177;&#160;0.13*</td>
###xml 2601 2615 2455 2467 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.84&#160;&#177;&#160;0.04*</td>
###xml 2545 2615 2407 2467 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">After</td><td align="left">22.9&#160;&#177;&#160;2.0</td><td align="left">1.4&#160;&#177;&#160;0.1</td><td align="left">5.53&#160;&#177;&#160;0.01*</td><td align="left">3.57&#160;&#177;&#160;0.13*</td><td align="left">0.84&#160;&#177;&#160;0.04*</td></tr>
###xml 2622 2623 2474 2475 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 2615 2623 2467 2475 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Control<sup>#</sup></td>
###xml 2623 2651 2475 2503 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">2 failing hearts; 6 myocytes</td>
###xml 2615 2651 2467 2503 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Control<sup>#</sup></td><td align="left" colspan="5">2 failing hearts; 6 myocytes</td></tr>
###xml 2651 2657 2503 2509 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Before</td>
###xml 2657 2669 2509 2519 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">22.7&#160;&#177;&#160;2.5</td>
###xml 2669 2680 2519 2528 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.5&#160;&#177;&#160;0.1</td>
###xml 2680 2693 2528 2539 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.66&#160;&#177;&#160;0.03</td>
###xml 2693 2706 2539 2550 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.16&#160;&#177;&#160;0.12</td>
###xml 2706 2719 2550 2561 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.64&#160;&#177;&#160;0.06</td>
###xml 2651 2719 2503 2561 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Before</td><td align="left">22.7&#160;&#177;&#160;2.5</td><td align="left">1.5&#160;&#177;&#160;0.1</td><td align="left">5.66&#160;&#177;&#160;0.03</td><td align="left">3.16&#160;&#177;&#160;0.12</td><td align="left">0.64&#160;&#177;&#160;0.06</td></tr>
###xml 2719 2724 2561 2566 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">After</td>
###xml 2724 2736 2566 2576 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">22.1&#160;&#177;&#160;2.5</td>
###xml 2736 2747 2576 2585 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.3&#160;&#177;&#160;0.1</td>
###xml 2747 2760 2585 2596 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.67&#160;&#177;&#160;0.03</td>
###xml 2760 2774 2596 2608 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.65&#160;&#177;&#160;0.11*</td>
###xml 2774 2787 2608 2619 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.74&#160;&#177;&#160;0.04</td>
###xml 2719 2787 2561 2619 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">After</td><td align="left">22.1&#160;&#177;&#160;2.5</td><td align="left">1.3&#160;&#177;&#160;0.1</td><td align="left">5.67&#160;&#177;&#160;0.03</td><td align="left">2.65&#160;&#177;&#160;0.11*</td><td align="left">0.74&#160;&#177;&#160;0.04</td></tr>
###xml 2787 2790 2619 2622 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6">(b)</td>
###xml 2787 2790 2619 2622 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6">(b)</td></tr>
###xml 2790 2792 2622 2624 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">AP</td>
###xml 2792 2821 2624 2653 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">5 failing hearts; 11 myocytes</td>
###xml 2790 2821 2622 2653 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">AP</td><td align="left" colspan="5">5 failing hearts; 11 myocytes</td></tr>
###xml 2821 2827 2653 2659 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Before</td>
###xml 2827 2839 2659 2669 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">35.7&#160;&#177;&#160;3.6</td>
###xml 2839 2850 2669 2678 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.8&#160;&#177;&#160;0.3</td>
###xml 2850 2863 2678 2689 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.64&#160;&#177;&#160;0.02</td>
###xml 2863 2876 2689 2700 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.68&#160;&#177;&#160;0.11</td>
###xml 2876 2889 2700 2711 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.76&#160;&#177;&#160;0.07</td>
###xml 2821 2889 2653 2711 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Before</td><td align="left">35.7&#160;&#177;&#160;3.6</td><td align="left">1.8&#160;&#177;&#160;0.3</td><td align="left">5.64&#160;&#177;&#160;0.02</td><td align="left">3.68&#160;&#177;&#160;0.11</td><td align="left">0.76&#160;&#177;&#160;0.07</td></tr>
###xml 2889 2894 2711 2716 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">After</td>
###xml 2894 2907 2716 2727 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">38.6&#160;&#177;&#160;4.5*</td>
###xml 2907 2919 2727 2737 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.5&#160;&#177;&#160;0.3*</td>
###xml 2919 2933 2737 2749 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.73&#160;&#177;&#160;0.03*</td>
###xml 2933 2947 2749 2761 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.85&#160;&#177;&#160;0.13*</td>
###xml 2947 2960 2761 2772 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.68&#160;&#177;&#160;0.04</td>
###xml 2889 2960 2711 2772 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">After</td><td align="left">38.6&#160;&#177;&#160;4.5*</td><td align="left">2.5&#160;&#177;&#160;0.3*</td><td align="left">5.73&#160;&#177;&#160;0.03*</td><td align="left">2.85&#160;&#177;&#160;0.13*</td><td align="left">0.68&#160;&#177;&#160;0.04</td></tr>
###xml 2960 2973 2772 2781 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">AP&#160;+&#160;PKC&#945;</td>
###xml 2973 3002 2781 2810 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">5 failing hearts; 10 myocytes</td>
###xml 2960 3002 2772 2810 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">AP&#160;+&#160;PKC&#945;</td><td align="left" colspan="5">5 failing hearts; 10 myocytes</td></tr>
###xml 3002 3008 2810 2816 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Before</td>
###xml 3008 3020 2816 2826 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">35.5&#160;&#177;&#160;3.8</td>
###xml 3020 3031 2826 2835 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.6&#160;&#177;&#160;0.3</td>
###xml 3031 3044 2835 2846 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.73&#160;&#177;&#160;0.03</td>
###xml 3044 3057 2846 2857 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.84&#160;&#177;&#160;0.14</td>
###xml 3057 3070 2857 2868 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.56&#160;&#177;&#160;0.06</td>
###xml 3002 3070 2810 2868 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Before</td><td align="left">35.5&#160;&#177;&#160;3.8</td><td align="left">2.6&#160;&#177;&#160;0.3</td><td align="left">5.73&#160;&#177;&#160;0.03</td><td align="left">2.84&#160;&#177;&#160;0.14</td><td align="left">0.56&#160;&#177;&#160;0.06</td></tr>
###xml 3070 3075 2868 2873 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">After</td>
###xml 3075 3087 2873 2883 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">35.1&#160;&#177;&#160;3.9</td>
###xml 3087 3098 2883 2892 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.4&#160;&#177;&#160;0.4</td>
###xml 3098 3112 2892 2904 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.60&#160;&#177;&#160;0.01*</td>
###xml 3112 3125 2904 2915 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.99&#160;&#177;&#160;0.15</td>
###xml 3125 3138 2915 2926 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.66&#160;&#177;&#160;0.09</td>
###xml 3070 3138 2868 2926 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">After</td><td align="left">35.1&#160;&#177;&#160;3.9</td><td align="left">2.4&#160;&#177;&#160;0.4</td><td align="left">5.60&#160;&#177;&#160;0.01*</td><td align="left">2.99&#160;&#177;&#160;0.15</td><td align="left">0.66&#160;&#177;&#160;0.09</td></tr>
###xml 3138 3140 2926 2928 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">AP</td>
###xml 3140 3166 2928 2954 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">4 donor hearts; 8 myocytes</td>
###xml 3138 3166 2926 2954 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">AP</td><td align="left" colspan="5">4 donor hearts; 8 myocytes</td></tr>
###xml 3166 3172 2954 2960 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Before</td>
###xml 3172 3184 2960 2970 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">34.1&#160;&#177;&#160;4.5</td>
###xml 3184 3195 2970 2979 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.5&#160;&#177;&#160;0.2</td>
###xml 3195 3208 2979 2990 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.48&#160;&#177;&#160;0.02</td>
###xml 3208 3221 2990 3001 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4.04&#160;&#177;&#160;0.19</td>
###xml 3221 3234 3001 3012 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.62&#160;&#177;&#160;0.09</td>
###xml 3166 3234 2954 3012 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Before</td><td align="left">34.1&#160;&#177;&#160;4.5</td><td align="left">1.5&#160;&#177;&#160;0.2</td><td align="left">5.48&#160;&#177;&#160;0.02</td><td align="left">4.04&#160;&#177;&#160;0.19</td><td align="left">0.62&#160;&#177;&#160;0.09</td></tr>
###xml 3234 3239 3012 3017 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">After</td>
###xml 3239 3251 3017 3027 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">34.3&#160;&#177;&#160;4.9</td>
###xml 3251 3263 3027 3037 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.0&#160;&#177;&#160;0.4*</td>
###xml 3263 3277 3037 3049 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.57&#160;&#177;&#160;0.02*</td>
###xml 3277 3291 3049 3061 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.33&#160;&#177;&#160;0.18*</td>
###xml 3291 3304 3061 3072 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.67&#160;&#177;&#160;0.07</td>
###xml 3234 3304 3012 3072 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">After</td><td align="left">34.3&#160;&#177;&#160;4.9</td><td align="left">2.0&#160;&#177;&#160;0.4*</td><td align="left">5.57&#160;&#177;&#160;0.02*</td><td align="left">3.33&#160;&#177;&#160;0.18*</td><td align="left">0.67&#160;&#177;&#160;0.07</td></tr>
###xml 3304 3317 3072 3081 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">AP&#160;+&#160;PKC&#945;</td>
###xml 3317 3343 3081 3107 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">4 donor hearts; 7 myocytes</td>
###xml 3304 3343 3072 3107 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">AP&#160;+&#160;PKC&#945;</td><td align="left" colspan="5">4 donor hearts; 7 myocytes</td></tr>
###xml 3343 3349 3107 3113 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Before</td>
###xml 3349 3361 3113 3123 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">31.6&#160;&#177;&#160;4.4</td>
###xml 3361 3372 3123 3132 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.2&#160;&#177;&#160;0.4</td>
###xml 3372 3385 3132 3143 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.59&#160;&#177;&#160;0.02</td>
###xml 3385 3398 3143 3154 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.25&#160;&#177;&#160;0.18</td>
###xml 3398 3411 3154 3165 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.57&#160;&#177;&#160;0.04</td>
###xml 3343 3411 3107 3165 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Before</td><td align="left">31.6&#160;&#177;&#160;4.4</td><td align="left">2.2&#160;&#177;&#160;0.4</td><td align="left">5.59&#160;&#177;&#160;0.02</td><td align="left">3.25&#160;&#177;&#160;0.18</td><td align="left">0.57&#160;&#177;&#160;0.04</td></tr>
###xml 3411 3416 3165 3170 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">After</td>
###xml 3416 3428 3170 3180 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">31.3&#160;&#177;&#160;4.8</td>
###xml 3428 3439 3180 3189 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.0&#160;&#177;&#160;0.4</td>
###xml 3439 3453 3189 3201 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.51&#160;&#177;&#160;0.02*</td>
###xml 3453 3466 3201 3212 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.30&#160;&#177;&#160;0.15</td>
###xml 3466 3480 3212 3224 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.76&#160;&#177;&#160;0.07*</td>
###xml 3411 3480 3165 3224 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">After</td><td align="left">31.3&#160;&#177;&#160;4.8</td><td align="left">2.0&#160;&#177;&#160;0.4</td><td align="left">5.51&#160;&#177;&#160;0.02*</td><td align="left">3.30&#160;&#177;&#160;0.15</td><td align="left">0.76&#160;&#177;&#160;0.07*</td></tr>
###xml 2092 3480 2014 3224 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="6">(a)</td></tr><tr><td align="left">PKC&#945;</td><td align="left" colspan="5">7 failing hearts; 14 myocytes</td></tr><tr><td align="left">Before</td><td align="left">28.2&#160;&#177;&#160;2.4</td><td align="left">1.5&#160;&#177;&#160;0.2</td><td align="left">5.67&#160;&#177;&#160;0.03</td><td align="left">3.43&#160;&#177;&#160;0.18</td><td align="left">0.69&#160;&#177;&#160;0.03</td></tr><tr><td align="left">After</td><td align="left">28.6&#160;&#177;&#160;2.4</td><td align="left">1.4&#160;&#177;&#160;0.2*</td><td align="left">5.59&#160;&#177;&#160;0.03*</td><td align="left">3.28&#160;&#177;&#160;0.24</td><td align="left">0.81&#160;&#177;&#160;0.04*</td></tr><tr><td align="left">PKC&#949;</td><td align="left" colspan="5">5 failing hearts; 7 myocytes</td></tr><tr><td align="left">Before</td><td align="left">30.3&#160;&#177;&#160;3.9</td><td align="left">1.6&#160;&#177;&#160;0.3</td><td align="left">5.68&#160;&#177;&#160;0.03</td><td align="left">3.86&#160;&#177;&#160;0.20</td><td align="left">0.60&#160;&#177;&#160;0.05</td></tr><tr><td align="left">After</td><td align="left">31.2&#160;&#177;&#160;3.1</td><td align="left">1.4&#160;&#177;&#160;0.2</td><td align="left">5.60&#160;&#177;&#160;0.02*</td><td align="left">3.42&#160;&#177;&#160;0.13</td><td align="left">0.74&#160;&#177;&#160;0.05*</td></tr><tr><td align="left">PKA</td><td align="left" colspan="5">7 failing hearts; 14 myocytes</td></tr><tr><td align="left">Before</td><td align="left">22.8&#160;&#177;&#160;2.1</td><td align="left">1.4&#160;&#177;&#160;0.2</td><td align="left">5.65&#160;&#177;&#160;0.02</td><td align="left">3.34&#160;&#177;&#160;0.07</td><td align="left">0.68&#160;&#177;&#160;0.02</td></tr><tr><td align="left">After</td><td align="left">22.9&#160;&#177;&#160;2.0</td><td align="left">1.4&#160;&#177;&#160;0.1</td><td align="left">5.53&#160;&#177;&#160;0.01*</td><td align="left">3.57&#160;&#177;&#160;0.13*</td><td align="left">0.84&#160;&#177;&#160;0.04*</td></tr><tr><td align="left">Control<sup>#</sup></td><td align="left" colspan="5">2 failing hearts; 6 myocytes</td></tr><tr><td align="left">Before</td><td align="left">22.7&#160;&#177;&#160;2.5</td><td align="left">1.5&#160;&#177;&#160;0.1</td><td align="left">5.66&#160;&#177;&#160;0.03</td><td align="left">3.16&#160;&#177;&#160;0.12</td><td align="left">0.64&#160;&#177;&#160;0.06</td></tr><tr><td align="left">After</td><td align="left">22.1&#160;&#177;&#160;2.5</td><td align="left">1.3&#160;&#177;&#160;0.1</td><td align="left">5.67&#160;&#177;&#160;0.03</td><td align="left">2.65&#160;&#177;&#160;0.11*</td><td align="left">0.74&#160;&#177;&#160;0.04</td></tr><tr><td align="left" colspan="6">(b)</td></tr><tr><td align="left">AP</td><td align="left" colspan="5">5 failing hearts; 11 myocytes</td></tr><tr><td align="left">Before</td><td align="left">35.7&#160;&#177;&#160;3.6</td><td align="left">1.8&#160;&#177;&#160;0.3</td><td align="left">5.64&#160;&#177;&#160;0.02</td><td align="left">3.68&#160;&#177;&#160;0.11</td><td align="left">0.76&#160;&#177;&#160;0.07</td></tr><tr><td align="left">After</td><td align="left">38.6&#160;&#177;&#160;4.5*</td><td align="left">2.5&#160;&#177;&#160;0.3*</td><td align="left">5.73&#160;&#177;&#160;0.03*</td><td align="left">2.85&#160;&#177;&#160;0.13*</td><td align="left">0.68&#160;&#177;&#160;0.04</td></tr><tr><td align="left">AP&#160;+&#160;PKC&#945;</td><td align="left" colspan="5">5 failing hearts; 10 myocytes</td></tr><tr><td align="left">Before</td><td align="left">35.5&#160;&#177;&#160;3.8</td><td align="left">2.6&#160;&#177;&#160;0.3</td><td align="left">5.73&#160;&#177;&#160;0.03</td><td align="left">2.84&#160;&#177;&#160;0.14</td><td align="left">0.56&#160;&#177;&#160;0.06</td></tr><tr><td align="left">After</td><td align="left">35.1&#160;&#177;&#160;3.9</td><td align="left">2.4&#160;&#177;&#160;0.4</td><td align="left">5.60&#160;&#177;&#160;0.01*</td><td align="left">2.99&#160;&#177;&#160;0.15</td><td align="left">0.66&#160;&#177;&#160;0.09</td></tr><tr><td align="left">AP</td><td align="left" colspan="5">4 donor hearts; 8 myocytes</td></tr><tr><td align="left">Before</td><td align="left">34.1&#160;&#177;&#160;4.5</td><td align="left">1.5&#160;&#177;&#160;0.2</td><td align="left">5.48&#160;&#177;&#160;0.02</td><td align="left">4.04&#160;&#177;&#160;0.19</td><td align="left">0.62&#160;&#177;&#160;0.09</td></tr><tr><td align="left">After</td><td align="left">34.3&#160;&#177;&#160;4.9</td><td align="left">2.0&#160;&#177;&#160;0.4*</td><td align="left">5.57&#160;&#177;&#160;0.02*</td><td align="left">3.33&#160;&#177;&#160;0.18*</td><td align="left">0.67&#160;&#177;&#160;0.07</td></tr><tr><td align="left">AP&#160;+&#160;PKC&#945;</td><td align="left" colspan="5">4 donor hearts; 7 myocytes</td></tr><tr><td align="left">Before</td><td align="left">31.6&#160;&#177;&#160;4.4</td><td align="left">2.2&#160;&#177;&#160;0.4</td><td align="left">5.59&#160;&#177;&#160;0.02</td><td align="left">3.25&#160;&#177;&#160;0.18</td><td align="left">0.57&#160;&#177;&#160;0.04</td></tr><tr><td align="left">After</td><td align="left">31.3&#160;&#177;&#160;4.8</td><td align="left">2.0&#160;&#177;&#160;0.4</td><td align="left">5.51&#160;&#177;&#160;0.02*</td><td align="left">3.30&#160;&#177;&#160;0.15</td><td align="left">0.76&#160;&#177;&#160;0.07*</td></tr></tbody>
###xml 2028 3480 1950 3224 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Incubation</th><th align="left" colspan="5">Cardiomyocyte measurements</th></tr><tr><th align="left"><italic>F</italic><sub>max</sub></th><th align="left"><italic>F</italic><sub>pas</sub></th><th align="left">pCa<sub>50</sub></th><th align="left">nH</th><th align="left"><italic>K</italic><sub>tr</sub>-max (s<sup>&#8722;1</sup>)</th></tr></thead><tbody><tr><td align="left" colspan="6">(a)</td></tr><tr><td align="left">PKC&#945;</td><td align="left" colspan="5">7 failing hearts; 14 myocytes</td></tr><tr><td align="left">Before</td><td align="left">28.2&#160;&#177;&#160;2.4</td><td align="left">1.5&#160;&#177;&#160;0.2</td><td align="left">5.67&#160;&#177;&#160;0.03</td><td align="left">3.43&#160;&#177;&#160;0.18</td><td align="left">0.69&#160;&#177;&#160;0.03</td></tr><tr><td align="left">After</td><td align="left">28.6&#160;&#177;&#160;2.4</td><td align="left">1.4&#160;&#177;&#160;0.2*</td><td align="left">5.59&#160;&#177;&#160;0.03*</td><td align="left">3.28&#160;&#177;&#160;0.24</td><td align="left">0.81&#160;&#177;&#160;0.04*</td></tr><tr><td align="left">PKC&#949;</td><td align="left" colspan="5">5 failing hearts; 7 myocytes</td></tr><tr><td align="left">Before</td><td align="left">30.3&#160;&#177;&#160;3.9</td><td align="left">1.6&#160;&#177;&#160;0.3</td><td align="left">5.68&#160;&#177;&#160;0.03</td><td align="left">3.86&#160;&#177;&#160;0.20</td><td align="left">0.60&#160;&#177;&#160;0.05</td></tr><tr><td align="left">After</td><td align="left">31.2&#160;&#177;&#160;3.1</td><td align="left">1.4&#160;&#177;&#160;0.2</td><td align="left">5.60&#160;&#177;&#160;0.02*</td><td align="left">3.42&#160;&#177;&#160;0.13</td><td align="left">0.74&#160;&#177;&#160;0.05*</td></tr><tr><td align="left">PKA</td><td align="left" colspan="5">7 failing hearts; 14 myocytes</td></tr><tr><td align="left">Before</td><td align="left">22.8&#160;&#177;&#160;2.1</td><td align="left">1.4&#160;&#177;&#160;0.2</td><td align="left">5.65&#160;&#177;&#160;0.02</td><td align="left">3.34&#160;&#177;&#160;0.07</td><td align="left">0.68&#160;&#177;&#160;0.02</td></tr><tr><td align="left">After</td><td align="left">22.9&#160;&#177;&#160;2.0</td><td align="left">1.4&#160;&#177;&#160;0.1</td><td align="left">5.53&#160;&#177;&#160;0.01*</td><td align="left">3.57&#160;&#177;&#160;0.13*</td><td align="left">0.84&#160;&#177;&#160;0.04*</td></tr><tr><td align="left">Control<sup>#</sup></td><td align="left" colspan="5">2 failing hearts; 6 myocytes</td></tr><tr><td align="left">Before</td><td align="left">22.7&#160;&#177;&#160;2.5</td><td align="left">1.5&#160;&#177;&#160;0.1</td><td align="left">5.66&#160;&#177;&#160;0.03</td><td align="left">3.16&#160;&#177;&#160;0.12</td><td align="left">0.64&#160;&#177;&#160;0.06</td></tr><tr><td align="left">After</td><td align="left">22.1&#160;&#177;&#160;2.5</td><td align="left">1.3&#160;&#177;&#160;0.1</td><td align="left">5.67&#160;&#177;&#160;0.03</td><td align="left">2.65&#160;&#177;&#160;0.11*</td><td align="left">0.74&#160;&#177;&#160;0.04</td></tr><tr><td align="left" colspan="6">(b)</td></tr><tr><td align="left">AP</td><td align="left" colspan="5">5 failing hearts; 11 myocytes</td></tr><tr><td align="left">Before</td><td align="left">35.7&#160;&#177;&#160;3.6</td><td align="left">1.8&#160;&#177;&#160;0.3</td><td align="left">5.64&#160;&#177;&#160;0.02</td><td align="left">3.68&#160;&#177;&#160;0.11</td><td align="left">0.76&#160;&#177;&#160;0.07</td></tr><tr><td align="left">After</td><td align="left">38.6&#160;&#177;&#160;4.5*</td><td align="left">2.5&#160;&#177;&#160;0.3*</td><td align="left">5.73&#160;&#177;&#160;0.03*</td><td align="left">2.85&#160;&#177;&#160;0.13*</td><td align="left">0.68&#160;&#177;&#160;0.04</td></tr><tr><td align="left">AP&#160;+&#160;PKC&#945;</td><td align="left" colspan="5">5 failing hearts; 10 myocytes</td></tr><tr><td align="left">Before</td><td align="left">35.5&#160;&#177;&#160;3.8</td><td align="left">2.6&#160;&#177;&#160;0.3</td><td align="left">5.73&#160;&#177;&#160;0.03</td><td align="left">2.84&#160;&#177;&#160;0.14</td><td align="left">0.56&#160;&#177;&#160;0.06</td></tr><tr><td align="left">After</td><td align="left">35.1&#160;&#177;&#160;3.9</td><td align="left">2.4&#160;&#177;&#160;0.4</td><td align="left">5.60&#160;&#177;&#160;0.01*</td><td align="left">2.99&#160;&#177;&#160;0.15</td><td align="left">0.66&#160;&#177;&#160;0.09</td></tr><tr><td align="left">AP</td><td align="left" colspan="5">4 donor hearts; 8 myocytes</td></tr><tr><td align="left">Before</td><td align="left">34.1&#160;&#177;&#160;4.5</td><td align="left">1.5&#160;&#177;&#160;0.2</td><td align="left">5.48&#160;&#177;&#160;0.02</td><td align="left">4.04&#160;&#177;&#160;0.19</td><td align="left">0.62&#160;&#177;&#160;0.09</td></tr><tr><td align="left">After</td><td align="left">34.3&#160;&#177;&#160;4.9</td><td align="left">2.0&#160;&#177;&#160;0.4*</td><td align="left">5.57&#160;&#177;&#160;0.02*</td><td align="left">3.33&#160;&#177;&#160;0.18*</td><td align="left">0.67&#160;&#177;&#160;0.07</td></tr><tr><td align="left">AP&#160;+&#160;PKC&#945;</td><td align="left" colspan="5">4 donor hearts; 7 myocytes</td></tr><tr><td align="left">Before</td><td align="left">31.6&#160;&#177;&#160;4.4</td><td align="left">2.2&#160;&#177;&#160;0.4</td><td align="left">5.59&#160;&#177;&#160;0.02</td><td align="left">3.25&#160;&#177;&#160;0.18</td><td align="left">0.57&#160;&#177;&#160;0.04</td></tr><tr><td align="left">After</td><td align="left">31.3&#160;&#177;&#160;4.8</td><td align="left">2.0&#160;&#177;&#160;0.4</td><td align="left">5.51&#160;&#177;&#160;0.02*</td><td align="left">3.30&#160;&#177;&#160;0.15</td><td align="left">0.76&#160;&#177;&#160;0.07*</td></tr></tbody></table>
###xml 3481 3484 3225 3228 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 3540 3541 3284 3285 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 3543 3544 3287 3288 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 3544 3548 3288 3292 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pass</sub>
###xml 3605 3606 3349 3350 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 3480 3645 3224 3389 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="30">F<sub>max</sub>, maximal force at maximal calcium concentration in kN/m<sup>2</sup>; <italic>F</italic><sub>pass</sub>, passive force measured in free calcium solution in kN/m<sup>2</sup>; nH, steepness of the force-pCa curves</p>
###xml 3647 3648 3391 3392 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 3698 3699 3442 3443 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 3645 3704 3389 3448 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="31">*&#160;<italic>P</italic>&#160;&lt;&#160;0.05, before versus after incubation in paired <italic>t</italic> test</p>
###xml 3704 3705 3448 3449 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 3704 3730 3448 3474 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><sup>#</sup>&#160;Time control incubations</p>
###xml 3480 3730 3224 3474 <table-wrap-foot xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="30">F<sub>max</sub>, maximal force at maximal calcium concentration in kN/m<sup>2</sup>; <italic>F</italic><sub>pass</sub>, passive force measured in free calcium solution in kN/m<sup>2</sup>; nH, steepness of the force-pCa curves</p><p textid="31">*&#160;<italic>P</italic>&#160;&lt;&#160;0.05, before versus after incubation in paired <italic>t</italic> test</p><p textid="32"><sup>#</sup>&#160;Time control incubations</p></table-wrap-foot>
###xml 1901 3730 1837 3474 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="29">Overview of the force measurements with PKC&#945;, PKC&#949; and PKA incubations (a) and AP and PKC&#945; incubations (b)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Incubation</th><th align="left" colspan="5">Cardiomyocyte measurements</th></tr><tr><th align="left"><italic>F</italic><sub>max</sub></th><th align="left"><italic>F</italic><sub>pas</sub></th><th align="left">pCa<sub>50</sub></th><th align="left">nH</th><th align="left"><italic>K</italic><sub>tr</sub>-max (s<sup>&#8722;1</sup>)</th></tr></thead><tbody><tr><td align="left" colspan="6">(a)</td></tr><tr><td align="left">PKC&#945;</td><td align="left" colspan="5">7 failing hearts; 14 myocytes</td></tr><tr><td align="left">Before</td><td align="left">28.2&#160;&#177;&#160;2.4</td><td align="left">1.5&#160;&#177;&#160;0.2</td><td align="left">5.67&#160;&#177;&#160;0.03</td><td align="left">3.43&#160;&#177;&#160;0.18</td><td align="left">0.69&#160;&#177;&#160;0.03</td></tr><tr><td align="left">After</td><td align="left">28.6&#160;&#177;&#160;2.4</td><td align="left">1.4&#160;&#177;&#160;0.2*</td><td align="left">5.59&#160;&#177;&#160;0.03*</td><td align="left">3.28&#160;&#177;&#160;0.24</td><td align="left">0.81&#160;&#177;&#160;0.04*</td></tr><tr><td align="left">PKC&#949;</td><td align="left" colspan="5">5 failing hearts; 7 myocytes</td></tr><tr><td align="left">Before</td><td align="left">30.3&#160;&#177;&#160;3.9</td><td align="left">1.6&#160;&#177;&#160;0.3</td><td align="left">5.68&#160;&#177;&#160;0.03</td><td align="left">3.86&#160;&#177;&#160;0.20</td><td align="left">0.60&#160;&#177;&#160;0.05</td></tr><tr><td align="left">After</td><td align="left">31.2&#160;&#177;&#160;3.1</td><td align="left">1.4&#160;&#177;&#160;0.2</td><td align="left">5.60&#160;&#177;&#160;0.02*</td><td align="left">3.42&#160;&#177;&#160;0.13</td><td align="left">0.74&#160;&#177;&#160;0.05*</td></tr><tr><td align="left">PKA</td><td align="left" colspan="5">7 failing hearts; 14 myocytes</td></tr><tr><td align="left">Before</td><td align="left">22.8&#160;&#177;&#160;2.1</td><td align="left">1.4&#160;&#177;&#160;0.2</td><td align="left">5.65&#160;&#177;&#160;0.02</td><td align="left">3.34&#160;&#177;&#160;0.07</td><td align="left">0.68&#160;&#177;&#160;0.02</td></tr><tr><td align="left">After</td><td align="left">22.9&#160;&#177;&#160;2.0</td><td align="left">1.4&#160;&#177;&#160;0.1</td><td align="left">5.53&#160;&#177;&#160;0.01*</td><td align="left">3.57&#160;&#177;&#160;0.13*</td><td align="left">0.84&#160;&#177;&#160;0.04*</td></tr><tr><td align="left">Control<sup>#</sup></td><td align="left" colspan="5">2 failing hearts; 6 myocytes</td></tr><tr><td align="left">Before</td><td align="left">22.7&#160;&#177;&#160;2.5</td><td align="left">1.5&#160;&#177;&#160;0.1</td><td align="left">5.66&#160;&#177;&#160;0.03</td><td align="left">3.16&#160;&#177;&#160;0.12</td><td align="left">0.64&#160;&#177;&#160;0.06</td></tr><tr><td align="left">After</td><td align="left">22.1&#160;&#177;&#160;2.5</td><td align="left">1.3&#160;&#177;&#160;0.1</td><td align="left">5.67&#160;&#177;&#160;0.03</td><td align="left">2.65&#160;&#177;&#160;0.11*</td><td align="left">0.74&#160;&#177;&#160;0.04</td></tr><tr><td align="left" colspan="6">(b)</td></tr><tr><td align="left">AP</td><td align="left" colspan="5">5 failing hearts; 11 myocytes</td></tr><tr><td align="left">Before</td><td align="left">35.7&#160;&#177;&#160;3.6</td><td align="left">1.8&#160;&#177;&#160;0.3</td><td align="left">5.64&#160;&#177;&#160;0.02</td><td align="left">3.68&#160;&#177;&#160;0.11</td><td align="left">0.76&#160;&#177;&#160;0.07</td></tr><tr><td align="left">After</td><td align="left">38.6&#160;&#177;&#160;4.5*</td><td align="left">2.5&#160;&#177;&#160;0.3*</td><td align="left">5.73&#160;&#177;&#160;0.03*</td><td align="left">2.85&#160;&#177;&#160;0.13*</td><td align="left">0.68&#160;&#177;&#160;0.04</td></tr><tr><td align="left">AP&#160;+&#160;PKC&#945;</td><td align="left" colspan="5">5 failing hearts; 10 myocytes</td></tr><tr><td align="left">Before</td><td align="left">35.5&#160;&#177;&#160;3.8</td><td align="left">2.6&#160;&#177;&#160;0.3</td><td align="left">5.73&#160;&#177;&#160;0.03</td><td align="left">2.84&#160;&#177;&#160;0.14</td><td align="left">0.56&#160;&#177;&#160;0.06</td></tr><tr><td align="left">After</td><td align="left">35.1&#160;&#177;&#160;3.9</td><td align="left">2.4&#160;&#177;&#160;0.4</td><td align="left">5.60&#160;&#177;&#160;0.01*</td><td align="left">2.99&#160;&#177;&#160;0.15</td><td align="left">0.66&#160;&#177;&#160;0.09</td></tr><tr><td align="left">AP</td><td align="left" colspan="5">4 donor hearts; 8 myocytes</td></tr><tr><td align="left">Before</td><td align="left">34.1&#160;&#177;&#160;4.5</td><td align="left">1.5&#160;&#177;&#160;0.2</td><td align="left">5.48&#160;&#177;&#160;0.02</td><td align="left">4.04&#160;&#177;&#160;0.19</td><td align="left">0.62&#160;&#177;&#160;0.09</td></tr><tr><td align="left">After</td><td align="left">34.3&#160;&#177;&#160;4.9</td><td align="left">2.0&#160;&#177;&#160;0.4*</td><td align="left">5.57&#160;&#177;&#160;0.02*</td><td align="left">3.33&#160;&#177;&#160;0.18*</td><td align="left">0.67&#160;&#177;&#160;0.07</td></tr><tr><td align="left">AP&#160;+&#160;PKC&#945;</td><td align="left" colspan="5">4 donor hearts; 7 myocytes</td></tr><tr><td align="left">Before</td><td align="left">31.6&#160;&#177;&#160;4.4</td><td align="left">2.2&#160;&#177;&#160;0.4</td><td align="left">5.59&#160;&#177;&#160;0.02</td><td align="left">3.25&#160;&#177;&#160;0.18</td><td align="left">0.57&#160;&#177;&#160;0.04</td></tr><tr><td align="left">After</td><td align="left">31.3&#160;&#177;&#160;4.8</td><td align="left">2.0&#160;&#177;&#160;0.4</td><td align="left">5.51&#160;&#177;&#160;0.02*</td><td align="left">3.30&#160;&#177;&#160;0.15</td><td align="left">0.76&#160;&#177;&#160;0.07*</td></tr></tbody></table><table-wrap-foot><p textid="30">F<sub>max</sub>, maximal force at maximal calcium concentration in kN/m<sup>2</sup>; <italic>F</italic><sub>pass</sub>, passive force measured in free calcium solution in kN/m<sup>2</sup>; nH, steepness of the force-pCa curves</p><p textid="31">*&#160;<italic>P</italic>&#160;&lt;&#160;0.05, before versus after incubation in paired <italic>t</italic> test</p><p textid="32"><sup>#</sup>&#160;Time control incubations</p></table-wrap-foot></table-wrap>
Direct incubation of the cardiomyocytes from failing hearts with saturating amounts of PKCalpha (n = 14 cardiomyocytes) and PKCepsilon (n = 7 cardiomyocytes) resulted in a decrease in Ca2+ sensitivity (pCa50) (Fig. 1a, b). Both PKC isoforms had no effect on maximal force (Fmax). Passive force (Fpas) was reduced after PKCalpha treatment, whereas PKCepsilon had no significant effect on Fpas (Table 2a). Fmax, Fpas and pCa50 did not change in the absence of kinases (time control; n = 6 failing cardiomyocytes), while the steepness of the force-pCa relationship (nH) slightly decreased (Table 2a).Fig. 1Effect of PKCalpha end epsilon phosphorylation of myofilament protein on Ca2+ sensitivity in failing myocardium. Ca2+ sensitivity of force was significantly decreased in failing cardiomyocytes after incubation with both PKCalpha (n = 14) (a) and PKCepsilon (n = 7) (b). The shifts in the mid-points of the curves (DeltapCa50) were very similar. Maximum force at saturating Ca2+ concentration was not affected. c Sypro and ProQ stained 1D gels of failing tissue samples incubated without kinases (C) d Effect of incubation of PKCalpha and PKCepsilon on phosphorylation of recombinant troponin complex in comparison to control incubation (C) and basal endogenous phosphorylation of cTnT and cTnI in a failing (F) sample. Upper panel Sypro staining. Lower panel ProQ staining. MHC myosin heavy chain, PM peppermintStick phosphoprotein marker (Molecular Probes). e Phosphorylation of myofilament proteins was expressed relative to the Sypro Ruby-stained cMyBP-C bands to correct for differences in protein loading. PKCalpha (n = 5) and PKCepsilon (n = 2) both significantly increased phosphorylation of endogenous myosin binding protein C (cMyBP-C) and troponin I (cTnI), while effects on desmin and troponin T (cTnT) were only small. *P < 0.05, PKC treatment versus control incubation in paired t testTable 2Overview of the force measurements with PKCalpha, PKCepsilon and PKA incubations (a) and AP and PKCalpha incubations (b)IncubationCardiomyocyte measurementsFmaxFpaspCa50nHKtr-max (s-1)(a)PKCalpha7 failing hearts; 14 myocytesBefore28.2 +/- 2.41.5 +/- 0.25.67 +/- 0.033.43 +/- 0.180.69 +/- 0.03After28.6 +/- 2.41.4 +/- 0.2*5.59 +/- 0.03*3.28 +/- 0.240.81 +/- 0.04*PKCepsilon5 failing hearts; 7 myocytesBefore30.3 +/- 3.91.6 +/- 0.35.68 +/- 0.033.86 +/- 0.200.60 +/- 0.05After31.2 +/- 3.11.4 +/- 0.25.60 +/- 0.02*3.42 +/- 0.130.74 +/- 0.05*PKA7 failing hearts; 14 myocytesBefore22.8 +/- 2.11.4 +/- 0.25.65 +/- 0.023.34 +/- 0.070.68 +/- 0.02After22.9 +/- 2.01.4 +/- 0.15.53 +/- 0.01*3.57 +/- 0.13*0.84 +/- 0.04*Control#2 failing hearts; 6 myocytesBefore22.7 +/- 2.51.5 +/- 0.15.66 +/- 0.033.16 +/- 0.120.64 +/- 0.06After22.1 +/- 2.51.3 +/- 0.15.67 +/- 0.032.65 +/- 0.11*0.74 +/- 0.04(b)AP5 failing hearts; 11 myocytesBefore35.7 +/- 3.61.8 +/- 0.35.64 +/- 0.023.68 +/- 0.110.76 +/- 0.07After38.6 +/- 4.5*2.5 +/- 0.3*5.73 +/- 0.03*2.85 +/- 0.13*0.68 +/- 0.04AP + PKCalpha5 failing hearts; 10 myocytesBefore35.5 +/- 3.82.6 +/- 0.35.73 +/- 0.032.84 +/- 0.140.56 +/- 0.06After35.1 +/- 3.92.4 +/- 0.45.60 +/- 0.01*2.99 +/- 0.150.66 +/- 0.09AP4 donor hearts; 8 myocytesBefore34.1 +/- 4.51.5 +/- 0.25.48 +/- 0.024.04 +/- 0.190.62 +/- 0.09After34.3 +/- 4.92.0 +/- 0.4*5.57 +/- 0.02*3.33 +/- 0.18*0.67 +/- 0.07AP + PKCalpha4 donor hearts; 7 myocytesBefore31.6 +/- 4.42.2 +/- 0.45.59 +/- 0.023.25 +/- 0.180.57 +/- 0.04After31.3 +/- 4.82.0 +/- 0.45.51 +/- 0.02*3.30 +/- 0.150.76 +/- 0.07*Fmax, maximal force at maximal calcium concentration in kN/m2; Fpass, passive force measured in free calcium solution in kN/m2; nH, steepness of the force-pCa curves* P < 0.05, before versus after incubation in paired t test# Time control incubations
###end p 27
###begin p 28
###xml 75 77 65 67 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 115 117 105 107 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 230 231 216 217 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 239 240 225 226 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 258 259 238 239 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 266 267 246 247 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 322 324 298 300 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 375 377 351 353 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 410 411 386 387 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 499 500 475 476 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 719 730 685 696 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Upper panel</italic>
###xml 747 758 713 724 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Lower panel</italic>
###xml 774 777 740 743 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MHC</italic>
###xml 798 800 764 766 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PM</italic>
###xml 859 860 825 826 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1021 1022 983 984 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1044 1045 1000 1001 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1232 1233 1188 1189 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1292 1293 1248 1249 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Effect of PKCalpha end epsilon phosphorylation of myofilament protein on Ca2+ sensitivity in failing myocardium. Ca2+ sensitivity of force was significantly decreased in failing cardiomyocytes after incubation with both PKCalpha (n = 14) (a) and PKCepsilon (n = 7) (b). The shifts in the mid-points of the curves (DeltapCa50) were very similar. Maximum force at saturating Ca2+ concentration was not affected. c Sypro and ProQ stained 1D gels of failing tissue samples incubated without kinases (C) d Effect of incubation of PKCalpha and PKCepsilon on phosphorylation of recombinant troponin complex in comparison to control incubation (C) and basal endogenous phosphorylation of cTnT and cTnI in a failing (F) sample. Upper panel Sypro staining. Lower panel ProQ staining. MHC myosin heavy chain, PM peppermintStick phosphoprotein marker (Molecular Probes). e Phosphorylation of myofilament proteins was expressed relative to the Sypro Ruby-stained cMyBP-C bands to correct for differences in protein loading. PKCalpha (n = 5) and PKCepsilon (n = 2) both significantly increased phosphorylation of endogenous myosin binding protein C (cMyBP-C) and troponin I (cTnI), while effects on desmin and troponin T (cTnT) were only small. *P < 0.05, PKC treatment versus control incubation in paired t test
###end p 28
###begin p 29
Overview of the force measurements with PKCalpha, PKCepsilon and PKA incubations (a) and AP and PKCalpha incubations (b)
###end p 29
###begin p 30
###xml 1 4 1 4 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 60 61 60 61 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 63 64 63 64 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 64 68 64 68 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pass</sub>
###xml 125 126 125 126 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Fmax, maximal force at maximal calcium concentration in kN/m2; Fpass, passive force measured in free calcium solution in kN/m2; nH, steepness of the force-pCa curves
###end p 30
###begin p 31
###xml 2 3 2 3 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 53 54 53 54 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
* P < 0.05, before versus after incubation in paired t test
###end p 31
###begin p 32
###xml 0 1 0 1 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
# Time control incubations
###end p 32
###begin p 33
###xml 7 8 7 8 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 708 710 673 675 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR43">43</xref>
###xml 966 967 911 912 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 684 689 <span type="species:ncbi:9606">human</span>
Figure 1c shows a phosphoprotein (ProQ) stained 1D gel of failing tissue samples treated with PKCalpha and PKCepsilon, at concentrations of 10 and 50 mug/mL. The phosphorylated active forms of PKCalpha and PKCepsilon became apparent in the incubations with 50 mug/mL kinase. Gels were subsequently stained with SYPRO Ruby to correct for differences in protein loading. The phosphorylation levels with 50 mug/mL kinase were similar to the incubations with 10 mug/mL kinase, indicating that the standard concentrations of 10 mug/mL kinase yielded the maximum obtainable phosphorylation level. To further investigate if PKCalpha and PKCepsilon are able to phosphorylate cTn, recombinant human troponin complex [43] was incubated with both isoforms. The results on the recombinant, non-phosphorylated troponin complex clearly indicate that PKCalpha and PKCepsilon both phosphorylate cTnT and cTnI and that the efficacy of PKCepsilon was less than that of PKCalpha (Fig. 1d).
###end p 33
###begin p 34
###xml 7 8 7 8 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 31 32 27 28 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 54 55 44 45 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 833 834 783 784 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 851 852 801 802 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 994 995 940 941 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1001 1007 947 953 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 1081 1082 1023 1024 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1099 1100 1041 1042 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1550 1551 1484 1485 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1553 1554 1487 1488 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1600 1601 1534 1535 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1007 1606 953 1540 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="35">Effect of PKC&#945; incubation on the phosphorylation of titin in failing (<italic>n</italic>&#160;=&#160;5) and donor (<italic>n</italic>&#160;=&#160;6) tissue. Sypro and ProQ stained agarose strengthened 5% sodium dodecyl sulfate-polyacrylamide gels of donor and failing tissue samples incubated with and without PKC&#945;. Phosphorylation of myofilament proteins was expressed relative to the Sypro Ruby-stained titin bands to correct for differences in protein loading. Incubation with PKC&#945; did not result in a significant increase of titin phosphorylation both in donor and failing tissue (<bold>a</bold>, <bold>b</bold>). Kinase versus control incubation in paired <italic>t</italic> test</p>
###xml 1007 1606 953 1540 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35">Effect of PKC&#945; incubation on the phosphorylation of titin in failing (<italic>n</italic>&#160;=&#160;5) and donor (<italic>n</italic>&#160;=&#160;6) tissue. Sypro and ProQ stained agarose strengthened 5% sodium dodecyl sulfate-polyacrylamide gels of donor and failing tissue samples incubated with and without PKC&#945;. Phosphorylation of myofilament proteins was expressed relative to the Sypro Ruby-stained titin bands to correct for differences in protein loading. Incubation with PKC&#945; did not result in a significant increase of titin phosphorylation both in donor and failing tissue (<bold>a</bold>, <bold>b</bold>). Kinase versus control incubation in paired <italic>t</italic> test</p></caption>
###xml 1606 1606 1540 1540 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="395_2009_53_Fig2_HTML" id="MO2"/>
###xml 1001 1606 947 1540 <fig xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="35">Effect of PKC&#945; incubation on the phosphorylation of titin in failing (<italic>n</italic>&#160;=&#160;5) and donor (<italic>n</italic>&#160;=&#160;6) tissue. Sypro and ProQ stained agarose strengthened 5% sodium dodecyl sulfate-polyacrylamide gels of donor and failing tissue samples incubated with and without PKC&#945;. Phosphorylation of myofilament proteins was expressed relative to the Sypro Ruby-stained titin bands to correct for differences in protein loading. Incubation with PKC&#945; did not result in a significant increase of titin phosphorylation both in donor and failing tissue (<bold>a</bold>, <bold>b</bold>). Kinase versus control incubation in paired <italic>t</italic> test</p></caption><graphic xlink:href="395_2009_53_Fig2_HTML" id="MO2"/></fig>
Figure 1e shows that PKCalpha (n = 5) and PKCepsilon (n = 2) caused pronounced (2- to 3-fold) increases in cTnI and cMyBP-C phosphorylation in failing myocardium (relative to the control incubation without kinase which was set to 1). The relative increase in cMyBP-C phosphorylation by PKCepsilon (3.4 +/- 0.5) was somewhat higher to that observed with PKCalpha (2.1 +/- 0.4), while phosphorylation of cTnI with PKCepsilon (1.6 +/- 0.1) was lower compared with PKCalpha (2.9 +/- 0.6). A minor increase in desmin phosphorylation was observed with both isoforms, while only PKCalpha slightly increased cTnT phosphorylation. No effects were observed on phosphorylation of myosin light chain 2 (MLC-2). As PKCalpha lowered passive force, the effect of PKCalpha incubation on the phosphorylation of cardiac titin was analyzed in failing (n = 5) and donor (n = 6) tissue. Incubation with PKCalpha did not result in a significant change in titin phosphorylation in both donor and failing tissue (Fig. 2a, b).Fig. 2Effect of PKCalpha incubation on the phosphorylation of titin in failing (n = 5) and donor (n = 6) tissue. Sypro and ProQ stained agarose strengthened 5% sodium dodecyl sulfate-polyacrylamide gels of donor and failing tissue samples incubated with and without PKCalpha. Phosphorylation of myofilament proteins was expressed relative to the Sypro Ruby-stained titin bands to correct for differences in protein loading. Incubation with PKCalpha did not result in a significant increase of titin phosphorylation both in donor and failing tissue (a, b). Kinase versus control incubation in paired t test
###end p 34
###begin p 35
###xml 74 75 70 71 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 92 93 88 89 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 543 544 531 532 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 546 547 534 535 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 593 594 581 582 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Effect of PKCalpha incubation on the phosphorylation of titin in failing (n = 5) and donor (n = 6) tissue. Sypro and ProQ stained agarose strengthened 5% sodium dodecyl sulfate-polyacrylamide gels of donor and failing tissue samples incubated with and without PKCalpha. Phosphorylation of myofilament proteins was expressed relative to the Sypro Ruby-stained titin bands to correct for differences in protein loading. Incubation with PKCalpha did not result in a significant increase of titin phosphorylation both in donor and failing tissue (a, b). Kinase versus control incubation in paired t test
###end p 35
###begin p 36
###xml 40 42 40 42 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 188 190 178 180 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 209 210 199 200 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 251 252 241 242 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 252 255 242 245 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 260 261 250 251 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 261 264 251 254 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pas</sub>
###xml 272 273 262 263 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 360 362 340 342 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 466 468 426 428 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 519 520 479 480 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 532 533 492 493 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 536 542 496 502 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 926 927 866 867 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 929 930 869 870 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 947 948 883 884 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 970 971 900 901 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1025 1027 945 947 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1111 1113 1031 1033 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1193 1194 1113 1114 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1196 1197 1116 1117 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1236 1238 1156 1158 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1254 1255 1170 1171 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1277 1278 1187 1188 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1284 1285 1194 1195 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 1285 1286 1195 1196 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1324 1325 1234 1235 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 542 1398 502 1308 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="37">PKC&#945; and &#949; do not cross-phosphorylate the PKA sites (Ser23/24). After the first force-pCa series (control, before incubation) myocytes from failing hearts were incubated with PKC&#945; or PKC&#949; and a second force-pCa series was measured. Thereafter the myocytes were incubated with PKA, which saturates the PKA sites on cTnI and the third force-pCa series was measured (<bold>a</bold>, <bold>b</bold>). PKC&#945;-PKA, <italic>n</italic>&#160;=&#160;9; PKC&#949;-PKA, <italic>n</italic>&#160;=&#160;7. PKC&#945; and PKC&#949; caused a reduction in Ca<sup>2+</sup> sensitivity and subsequent incubation with PKA results in a further reduction of Ca<sup>2+</sup> sensitivity. Reversal of the order of application of the PKC isoforms and PKA (<bold>c</bold>, <bold>d</bold>) resulted in similar reductions in pCa<sub>50</sub>. PKA&#8211;PKC&#945;, <italic>n</italic>&#160;=&#160;8; PKA&#8211;PKC&#949;, <italic>n</italic>&#160;=&#160;6. <sup>#</sup><italic>P</italic>&#160;&lt;&#160;0.05, in repeated measures ANOVA. *<italic>P</italic>&#160;&lt;&#160;0.05, before versus after kinase treatment in Bonferroni post hoc test</p>
###xml 542 1398 502 1308 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="37">PKC&#945; and &#949; do not cross-phosphorylate the PKA sites (Ser23/24). After the first force-pCa series (control, before incubation) myocytes from failing hearts were incubated with PKC&#945; or PKC&#949; and a second force-pCa series was measured. Thereafter the myocytes were incubated with PKA, which saturates the PKA sites on cTnI and the third force-pCa series was measured (<bold>a</bold>, <bold>b</bold>). PKC&#945;-PKA, <italic>n</italic>&#160;=&#160;9; PKC&#949;-PKA, <italic>n</italic>&#160;=&#160;7. PKC&#945; and PKC&#949; caused a reduction in Ca<sup>2+</sup> sensitivity and subsequent incubation with PKA results in a further reduction of Ca<sup>2+</sup> sensitivity. Reversal of the order of application of the PKC isoforms and PKA (<bold>c</bold>, <bold>d</bold>) resulted in similar reductions in pCa<sub>50</sub>. PKA&#8211;PKC&#945;, <italic>n</italic>&#160;=&#160;8; PKA&#8211;PKC&#949;, <italic>n</italic>&#160;=&#160;6. <sup>#</sup><italic>P</italic>&#160;&lt;&#160;0.05, in repeated measures ANOVA. *<italic>P</italic>&#160;&lt;&#160;0.05, before versus after kinase treatment in Bonferroni post hoc test</p></caption>
###xml 1398 1398 1308 1308 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="395_2009_53_Fig3_HTML" id="MO3"/>
###xml 536 1398 496 1308 <fig xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="37">PKC&#945; and &#949; do not cross-phosphorylate the PKA sites (Ser23/24). After the first force-pCa series (control, before incubation) myocytes from failing hearts were incubated with PKC&#945; or PKC&#949; and a second force-pCa series was measured. Thereafter the myocytes were incubated with PKA, which saturates the PKA sites on cTnI and the third force-pCa series was measured (<bold>a</bold>, <bold>b</bold>). PKC&#945;-PKA, <italic>n</italic>&#160;=&#160;9; PKC&#949;-PKA, <italic>n</italic>&#160;=&#160;7. PKC&#945; and PKC&#949; caused a reduction in Ca<sup>2+</sup> sensitivity and subsequent incubation with PKA results in a further reduction of Ca<sup>2+</sup> sensitivity. Reversal of the order of application of the PKC isoforms and PKA (<bold>c</bold>, <bold>d</bold>) resulted in similar reductions in pCa<sub>50</sub>. PKA&#8211;PKC&#945;, <italic>n</italic>&#160;=&#160;8; PKA&#8211;PKC&#949;, <italic>n</italic>&#160;=&#160;6. <sup>#</sup><italic>P</italic>&#160;&lt;&#160;0.05, in repeated measures ANOVA. *<italic>P</italic>&#160;&lt;&#160;0.05, before versus after kinase treatment in Bonferroni post hoc test</p></caption><graphic xlink:href="395_2009_53_Fig3_HTML" id="MO3"/></fig>
To address the origin of the shift in Ca2+ sensitivity in failing hearts, cells were treated with PKA after incubation with PKCalpha and epsilon. This resulted in a further reduction in Ca2+ sensitivity (Fig. 3a, b), without any significant effect on Fmax and Fpas (Table 2a). Reversal of the PKA and PKCalpha/epsilon sequences yielded similar reductions in Ca2+ sensitivity for PKA and PKCalpha and epsilon, indicating that the effects of PKCalpha and epsilon on Ca2+ sensitivity were independent of that of PKA (Fig. 3c, d; Table 2a).Fig. 3PKCalpha and epsilon do not cross-phosphorylate the PKA sites (Ser23/24). After the first force-pCa series (control, before incubation) myocytes from failing hearts were incubated with PKCalpha or PKCepsilon and a second force-pCa series was measured. Thereafter the myocytes were incubated with PKA, which saturates the PKA sites on cTnI and the third force-pCa series was measured (a, b). PKCalpha-PKA, n = 9; PKCepsilon-PKA, n = 7. PKCalpha and PKCepsilon caused a reduction in Ca2+ sensitivity and subsequent incubation with PKA results in a further reduction of Ca2+ sensitivity. Reversal of the order of application of the PKC isoforms and PKA (c, d) resulted in similar reductions in pCa50. PKA-PKCalpha, n = 8; PKA-PKCepsilon, n = 6. #P < 0.05, in repeated measures ANOVA. *P < 0.05, before versus after kinase treatment in Bonferroni post hoc test
###end p 36
###begin p 37
###xml 384 385 364 365 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 387 388 367 368 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 405 406 381 382 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 428 429 398 399 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 483 485 443 445 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 569 571 529 531 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 651 652 611 612 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 654 655 614 615 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 694 696 654 656 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 712 713 668 669 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 735 736 685 686 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 742 743 692 693 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 743 744 693 694 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 782 783 732 733 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
PKCalpha and epsilon do not cross-phosphorylate the PKA sites (Ser23/24). After the first force-pCa series (control, before incubation) myocytes from failing hearts were incubated with PKCalpha or PKCepsilon and a second force-pCa series was measured. Thereafter the myocytes were incubated with PKA, which saturates the PKA sites on cTnI and the third force-pCa series was measured (a, b). PKCalpha-PKA, n = 9; PKCepsilon-PKA, n = 7. PKCalpha and PKCepsilon caused a reduction in Ca2+ sensitivity and subsequent incubation with PKA results in a further reduction of Ca2+ sensitivity. Reversal of the order of application of the PKC isoforms and PKA (c, d) resulted in similar reductions in pCa50. PKA-PKCalpha, n = 8; PKA-PKCepsilon, n = 6. #P < 0.05, in repeated measures ANOVA. *P < 0.05, before versus after kinase treatment in Bonferroni post hoc test
###end p 37
###begin p 38
###xml 12 13 12 13 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 13 15 13 15 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">tr</sub>
###xml 50 52 50 52 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 67 69 67 69 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 192 193 182 183 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 242 243 232 233 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 243 245 233 235 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">tr</sub>
###xml 387 388 377 378 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
On average, Ktr-max [tension redevelopment rate (s-1) at maximal Ca2+ concentration] was significantly increased after PKCalpha, PKCepsilon and PKA incubation in failing cardiomyocytes (Table 2a). However, it must be noted that the change in Ktr-max in failing cells upon kinase treatments did not significantly differ from the increase observed in the (time) control incubations (Table 2a). These results suggest that the kinases and phosphatase used have little, if any, effect on the kinetics of force redevelopment at saturating calcium concentration.
###end p 38
###begin title 39
###xml 21 23 17 19 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
PKCalpha decreases Ca2+ sensitivity via cTnT phosphorylation
###end title 39
###begin p 40
###xml 33 35 33 35 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 37 39 37 39 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 323 324 323 324 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 328 329 328 329 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 329 332 329 332 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 337 338 337 338 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 338 341 338 341 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pas</sub>
###xml 388 389 388 389 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 396 397 396 397 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 397 400 397 400 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 418 419 416 417 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 424 425 422 423 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 425 428 423 426 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pas</sub>
###xml 445 446 441 442 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 459 460 455 456 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 467 468 463 464 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 468 471 464 467 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 489 490 483 484 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 495 496 489 490 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 496 499 490 493 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pas</sub>
###xml 516 517 508 509 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 543 545 535 537 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 630 631 620 621 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 672 673 660 661 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 799 800 785 786 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 841 842 825 826 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 856 857 840 841 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 867 868 851 852 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 868 870 852 854 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">tr</sub>
###xml 949 951 931 933 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 953 954 935 936 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 991 993 971 973 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 995 996 975 976 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1170 1172 1150 1152 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 1520 1521 1492 1493 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 2082 2083 2042 2043 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 2086 2092 2046 2052 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 2205 2206 2161 2162 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2330 2331 2286 2287 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2369 2370 2325 2326 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2386 2387 2342 2343 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2429 2430 2385 2386 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 2437 2438 2393 2394 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2531 2532 2483 2484 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 2597 2598 2544 2545 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2717 2718 2662 2663 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2770 2771 2715 2716 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 2092 2776 2052 2721 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="41">Basal phosphorylation of donor versus failing tissue and the effect of PKC&#945; phosphorylation on donor tissue. <bold>a</bold> Endogenous phosphorylation of myosin binding protein C (cMyBP-C) and troponin I (cTnI) was significantly lower in failing (<italic>n</italic>&#160;=&#160;10) compared to non-failing donor (<italic>n</italic>&#160;=&#160;4) samples. *<italic>P</italic>&#160;&lt;&#160;0.05, donor versus failing in unpaired <italic>t</italic> test. <bold>b</bold> PKC&#945; treatment did not alter force characteristics of non-failing donor cardiomyocytes. <bold>c</bold> Average data using 10&#160;&#956;g/mL of PKC&#945; in samples from donor (<italic>n</italic>&#160;=&#160;4) hearts. In donor tissue the only significant effect was a small (9&#160;&#177;&#160;3%) increase in cMyBP-C phosphorylation. *<italic>P</italic>&#160;&lt;&#160;0.05, kinase versus control incubation in paired <italic>t</italic> test</p>
###xml 2092 2776 2052 2721 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="41">Basal phosphorylation of donor versus failing tissue and the effect of PKC&#945; phosphorylation on donor tissue. <bold>a</bold> Endogenous phosphorylation of myosin binding protein C (cMyBP-C) and troponin I (cTnI) was significantly lower in failing (<italic>n</italic>&#160;=&#160;10) compared to non-failing donor (<italic>n</italic>&#160;=&#160;4) samples. *<italic>P</italic>&#160;&lt;&#160;0.05, donor versus failing in unpaired <italic>t</italic> test. <bold>b</bold> PKC&#945; treatment did not alter force characteristics of non-failing donor cardiomyocytes. <bold>c</bold> Average data using 10&#160;&#956;g/mL of PKC&#945; in samples from donor (<italic>n</italic>&#160;=&#160;4) hearts. In donor tissue the only significant effect was a small (9&#160;&#177;&#160;3%) increase in cMyBP-C phosphorylation. *<italic>P</italic>&#160;&lt;&#160;0.05, kinase versus control incubation in paired <italic>t</italic> test</p></caption>
###xml 2776 2776 2721 2721 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="395_2009_53_Fig4_HTML" id="MO4"/>
###xml 2086 2776 2046 2721 <fig xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="41">Basal phosphorylation of donor versus failing tissue and the effect of PKC&#945; phosphorylation on donor tissue. <bold>a</bold> Endogenous phosphorylation of myosin binding protein C (cMyBP-C) and troponin I (cTnI) was significantly lower in failing (<italic>n</italic>&#160;=&#160;10) compared to non-failing donor (<italic>n</italic>&#160;=&#160;4) samples. *<italic>P</italic>&#160;&lt;&#160;0.05, donor versus failing in unpaired <italic>t</italic> test. <bold>b</bold> PKC&#945; treatment did not alter force characteristics of non-failing donor cardiomyocytes. <bold>c</bold> Average data using 10&#160;&#956;g/mL of PKC&#945; in samples from donor (<italic>n</italic>&#160;=&#160;4) hearts. In donor tissue the only significant effect was a small (9&#160;&#177;&#160;3%) increase in cMyBP-C phosphorylation. *<italic>P</italic>&#160;&lt;&#160;0.05, kinase versus control incubation in paired <italic>t</italic> test</p></caption><graphic xlink:href="395_2009_53_Fig4_HTML" id="MO4"/></fig>
###xml 2776 2782 2721 2727 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;5</label>
###xml 2938 2939 2879 2880 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 3134 3136 3063 3065 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MM</italic>
###xml 3162 3164 3091 3093 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PM</italic>
###xml 3223 3224 3152 3153 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 3323 3324 3252 3253 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3341 3342 3270 3271 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3360 3361 3289 3290 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 3477 3478 3402 3403 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3501 3502 3426 3427 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 3550 3551 3471 3472 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 2782 3556 2727 3477 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="42">Effect of alkaline phosphatase (AP) treatment and the subsequent effect of PKC&#945; on myofilament protein phosphorylation in donor and failing myocardium. <bold>a</bold> 1D gradient gel stained with ProQ diamond from donor and failing myocardium incubated without kinase or phosphatase (C), with PKC&#945;, with AP and with AP followed by PKC&#945; (AP&#160;+&#160;PKC&#945;). <italic>MM</italic> molecular weight marker, <italic>PM</italic> PeppermintStick Phosphoprotein marker (Molecular Probes). <bold>b</bold> Changes in phosphorylation of cTnT by AP relative to time control without phosphatase in failing (<italic>n</italic>&#160;=&#160;5) and donor (<italic>n</italic>&#160;=&#160;6) myocardium. <bold>c</bold> Changes in phosphorylation by PKC&#945; upon AP pretreatment relative to the values obtained after AP pretreatment (<italic>n</italic>&#160;=&#160;4 in both groups). *<italic>P</italic>&#160;&lt;&#160;0.05, PKC&#945; relative to control in paired <italic>t</italic> test</p>
###xml 2782 3556 2727 3477 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42">Effect of alkaline phosphatase (AP) treatment and the subsequent effect of PKC&#945; on myofilament protein phosphorylation in donor and failing myocardium. <bold>a</bold> 1D gradient gel stained with ProQ diamond from donor and failing myocardium incubated without kinase or phosphatase (C), with PKC&#945;, with AP and with AP followed by PKC&#945; (AP&#160;+&#160;PKC&#945;). <italic>MM</italic> molecular weight marker, <italic>PM</italic> PeppermintStick Phosphoprotein marker (Molecular Probes). <bold>b</bold> Changes in phosphorylation of cTnT by AP relative to time control without phosphatase in failing (<italic>n</italic>&#160;=&#160;5) and donor (<italic>n</italic>&#160;=&#160;6) myocardium. <bold>c</bold> Changes in phosphorylation by PKC&#945; upon AP pretreatment relative to the values obtained after AP pretreatment (<italic>n</italic>&#160;=&#160;4 in both groups). *<italic>P</italic>&#160;&lt;&#160;0.05, PKC&#945; relative to control in paired <italic>t</italic> test</p></caption>
###xml 3556 3556 3477 3477 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="395_2009_53_Fig5_HTML" id="MO5"/>
###xml 2776 3556 2721 3477 <fig xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig5"><label>Fig.&#160;5</label><caption><p textid="42">Effect of alkaline phosphatase (AP) treatment and the subsequent effect of PKC&#945; on myofilament protein phosphorylation in donor and failing myocardium. <bold>a</bold> 1D gradient gel stained with ProQ diamond from donor and failing myocardium incubated without kinase or phosphatase (C), with PKC&#945;, with AP and with AP followed by PKC&#945; (AP&#160;+&#160;PKC&#945;). <italic>MM</italic> molecular weight marker, <italic>PM</italic> PeppermintStick Phosphoprotein marker (Molecular Probes). <bold>b</bold> Changes in phosphorylation of cTnT by AP relative to time control without phosphatase in failing (<italic>n</italic>&#160;=&#160;5) and donor (<italic>n</italic>&#160;=&#160;6) myocardium. <bold>c</bold> Changes in phosphorylation by PKC&#945; upon AP pretreatment relative to the values obtained after AP pretreatment (<italic>n</italic>&#160;=&#160;4 in both groups). *<italic>P</italic>&#160;&lt;&#160;0.05, PKC&#945; relative to control in paired <italic>t</italic> test</p></caption><graphic xlink:href="395_2009_53_Fig5_HTML" id="MO5"/></fig>
###xml 1250 1255 <span type="species:ncbi:9606">human</span>
As observed in a previous study [14, 36], analysis of baseline endogenous myofilament protein phosphorylation revealed significantly higher cMyBP-C and cTnI phosphorylation in donor samples in comparison to failing samples, while no significant differences in phosphorylation were observed for desmin, cTnT and MLC-2 (Fig. 4a). Fmax and Fpas did not significantly differ between failing (n = 56; Fmax 31.7 +/- 1.5 kN/m2 and Fpas 1.6 +/- 0.1 kN/m2) and donor (n = 20; Fmax 33.8 +/- 3.0 kN/m2 and Fpas 1.8 +/- 0.2 kN/m2) cardiomyocytes, while Ca2+ sensitivity of the myofilaments was significantly higher in failing (5.66 +/- 0.01; n = 54) compared to donor (5.50 +/- 0.01; n = 20) myocardium. In addition the steepness of the pCa-force relationship (nH) was slightly lower in failing (3.48 +/- 0.09; n = 54) compared to donor (3.85 +/- 0.19; n = 20) cells (P < 0.05). Ktr-max was slightly, though not significantly, higher in failing (0.84 +/- 0.02 s-1; n = 56) than in donor (0.77 +/- 0.03 s-1; n = 20) cells. Previous analysis using two-dimensional gel electrophoresis revealed that endogenous cTnT phosphorylation is high (~63%), both in donor and failing myocardium [36]. To uncover functional effects of PKCalpha-mediated cTnT phosphorylation in human tissue, PKCalpha incubations were repeated after pretreatment of failing and donor cardiomyocytes with AP. AP significantly reduced cTnT phosphorylation to 15% of its original level in donor and to 17% in failing myocardium without dephosphorylation of cTnI (Fig. 5a, b). AP treatment also significantly reduced phosphorylation of cMyBP-C (~30%) in donor myocardium, and of desmin (~30%) in failing tissue. Subsequent phosphorylation by PKCalpha of samples dephosphorylated by AP resulted in significant increases in cTnT phosphorylation in failing (170%) and in donor tissue (95%). In addition, PKCalpha significantly increased phosphorylation of cMyBP-C (~23%), desmin (~113%), cTnI (~160%) and MLC-2 (~80%) in failing tissue, while in AP pre-treated donor tissue, cTnT was the only protein phosphorylated by PKCalpha (Fig. 5c).Fig. 4Basal phosphorylation of donor versus failing tissue and the effect of PKCalpha phosphorylation on donor tissue. a Endogenous phosphorylation of myosin binding protein C (cMyBP-C) and troponin I (cTnI) was significantly lower in failing (n = 10) compared to non-failing donor (n = 4) samples. *P < 0.05, donor versus failing in unpaired t test. b PKCalpha treatment did not alter force characteristics of non-failing donor cardiomyocytes. c Average data using 10 mug/mL of PKCalpha in samples from donor (n = 4) hearts. In donor tissue the only significant effect was a small (9 +/- 3%) increase in cMyBP-C phosphorylation. *P < 0.05, kinase versus control incubation in paired t testFig. 5Effect of alkaline phosphatase (AP) treatment and the subsequent effect of PKCalpha on myofilament protein phosphorylation in donor and failing myocardium. a 1D gradient gel stained with ProQ diamond from donor and failing myocardium incubated without kinase or phosphatase (C), with PKCalpha, with AP and with AP followed by PKCalpha (AP + PKCalpha). MM molecular weight marker, PM PeppermintStick Phosphoprotein marker (Molecular Probes). b Changes in phosphorylation of cTnT by AP relative to time control without phosphatase in failing (n = 5) and donor (n = 6) myocardium. c Changes in phosphorylation by PKCalpha upon AP pretreatment relative to the values obtained after AP pretreatment (n = 4 in both groups). *P < 0.05, PKCalpha relative to control in paired t test
###end p 40
###begin p 41
###xml 113 114 109 110 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 238 239 234 235 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 277 278 273 274 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 294 295 290 291 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 337 338 333 334 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 345 346 341 342 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 439 440 431 432 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 505 506 492 493 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 625 626 610 611 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 678 679 663 664 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Basal phosphorylation of donor versus failing tissue and the effect of PKCalpha phosphorylation on donor tissue. a Endogenous phosphorylation of myosin binding protein C (cMyBP-C) and troponin I (cTnI) was significantly lower in failing (n = 10) compared to non-failing donor (n = 4) samples. *P < 0.05, donor versus failing in unpaired t test. b PKCalpha treatment did not alter force characteristics of non-failing donor cardiomyocytes. c Average data using 10 mug/mL of PKCalpha in samples from donor (n = 4) hearts. In donor tissue the only significant effect was a small (9 +/- 3%) increase in cMyBP-C phosphorylation. *P < 0.05, kinase versus control incubation in paired t test
###end p 41
###begin p 42
###xml 156 157 152 153 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 352 354 336 338 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MM</italic>
###xml 380 382 364 366 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PM</italic>
###xml 441 442 425 426 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 541 542 525 526 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 559 560 543 544 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 578 579 562 563 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 695 696 675 676 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 719 720 699 700 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 768 769 744 745 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Effect of alkaline phosphatase (AP) treatment and the subsequent effect of PKCalpha on myofilament protein phosphorylation in donor and failing myocardium. a 1D gradient gel stained with ProQ diamond from donor and failing myocardium incubated without kinase or phosphatase (C), with PKCalpha, with AP and with AP followed by PKCalpha (AP + PKCalpha). MM molecular weight marker, PM PeppermintStick Phosphoprotein marker (Molecular Probes). b Changes in phosphorylation of cTnT by AP relative to time control without phosphatase in failing (n = 5) and donor (n = 6) myocardium. c Changes in phosphorylation by PKCalpha upon AP pretreatment relative to the values obtained after AP pretreatment (n = 4 in both groups). *P < 0.05, PKCalpha relative to control in paired t test
###end p 42
###begin p 43
###xml 151 153 147 149 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 219 220 215 216 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 234 236 226 228 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 308 310 296 298 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 338 340 326 328 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 510 511 486 487 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 639 640 611 612 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 684 686 656 658 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 852 853 824 825 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 853 856 825 828 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 880 881 852 853 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 906 907 878 879 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 923 924 895 896 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 924 927 896 899 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 993 994 961 962 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 994 997 962 965 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 1055 1056 1023 1024 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1056 1059 1024 1027 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pas</sub>
###xml 1098 1099 1066 1067 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 1178 1184 1142 1148 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;6</label>
###xml 1281 1282 1241 1242 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1299 1300 1259 1260 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1316 1318 1276 1278 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1475 1476 1431 1432 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1478 1479 1434 1435 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1558 1559 1514 1515 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1559 1562 1515 1518 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 1628 1629 1584 1585 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1631 1632 1587 1588 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1687 1688 1639 1640 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1688 1691 1640 1643 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 1708 1709 1660 1661 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1709 1712 1661 1664 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pas</sub>
###xml 1715 1716 1667 1668 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1718 1719 1670 1671 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1821 1822 1769 1770 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1184 1907 1148 1855 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="44">The effects of PKC&#945; after dephosphorylation of cTnT by alkaline phosphatase (AP) in failing (<italic>n</italic>&#160;=&#160;5) and donor (<italic>n</italic>&#160;=&#160;4) tissue. Ca<sup>2+</sup> sensitivity of force was increased after AP treatment and was subsequently reduced after PKC&#945; treatment to the levels observed without AP pretreatment (<bold>a</bold>, <bold>b</bold>). AP treatment resulted in a minor but significant increase in maximum force (<italic>F</italic><sub>max</sub>) in failing tissue while in donor tissue no change was observed (<bold>c</bold>, <bold>d</bold>). Subsequent treatment with PKC&#945; had no effect on <italic>F</italic><sub>max</sub>. Passive force (<italic>F</italic><sub>pas</sub>) (<bold>e</bold>, <bold>f</bold>) was increased after AP in failing and donor tissue and remained elevated after PKC&#945; treatment. *<italic>P</italic>&#160;&lt;&#160;0.05, before versus after phosphatase/kinase treatment in Bonferroni post hoc test</p>
###xml 1184 1907 1148 1855 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="44">The effects of PKC&#945; after dephosphorylation of cTnT by alkaline phosphatase (AP) in failing (<italic>n</italic>&#160;=&#160;5) and donor (<italic>n</italic>&#160;=&#160;4) tissue. Ca<sup>2+</sup> sensitivity of force was increased after AP treatment and was subsequently reduced after PKC&#945; treatment to the levels observed without AP pretreatment (<bold>a</bold>, <bold>b</bold>). AP treatment resulted in a minor but significant increase in maximum force (<italic>F</italic><sub>max</sub>) in failing tissue while in donor tissue no change was observed (<bold>c</bold>, <bold>d</bold>). Subsequent treatment with PKC&#945; had no effect on <italic>F</italic><sub>max</sub>. Passive force (<italic>F</italic><sub>pas</sub>) (<bold>e</bold>, <bold>f</bold>) was increased after AP in failing and donor tissue and remained elevated after PKC&#945; treatment. *<italic>P</italic>&#160;&lt;&#160;0.05, before versus after phosphatase/kinase treatment in Bonferroni post hoc test</p></caption>
###xml 1907 1907 1855 1855 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="395_2009_53_Fig6_HTML" id="MO6"/>
###xml 1178 1907 1142 1855 <fig xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig6"><label>Fig.&#160;6</label><caption><p textid="44">The effects of PKC&#945; after dephosphorylation of cTnT by alkaline phosphatase (AP) in failing (<italic>n</italic>&#160;=&#160;5) and donor (<italic>n</italic>&#160;=&#160;4) tissue. Ca<sup>2+</sup> sensitivity of force was increased after AP treatment and was subsequently reduced after PKC&#945; treatment to the levels observed without AP pretreatment (<bold>a</bold>, <bold>b</bold>). AP treatment resulted in a minor but significant increase in maximum force (<italic>F</italic><sub>max</sub>) in failing tissue while in donor tissue no change was observed (<bold>c</bold>, <bold>d</bold>). Subsequent treatment with PKC&#945; had no effect on <italic>F</italic><sub>max</sub>. Passive force (<italic>F</italic><sub>pas</sub>) (<bold>e</bold>, <bold>f</bold>) was increased after AP in failing and donor tissue and remained elevated after PKC&#945; treatment. *<italic>P</italic>&#160;&lt;&#160;0.05, before versus after phosphatase/kinase treatment in Bonferroni post hoc test</p></caption><graphic xlink:href="395_2009_53_Fig6_HTML" id="MO6"/></fig>
After the massive dephosphorylation of cTnT, the effects of PKCalpha on cardiomyocyte function were studied. AP treatment resulted in an increase in Ca2+ sensitivity, which was similar in failing and donor tissue (Fig. 6a, b; DeltapCa50 = 0.09). Subsequent treatment with PKCalpha resulted in a decline in Ca2+ sensitivity to a level (pCa50 after AP-PKCalpha: 5.60 +/- 0.01 and 5.51 +/- 0.02 in failing and donor, respectively) similar to that observed after PKCalpha treatment, without AP pretreatment (Table 2b). The steepness of the force-pCa relation decreased upon AP in failing and donor cells and remained low after PKCalpha (Table 2b). A similar decline in steepness of the Ca2+ sensitivity curve was observed in the time control experiments in the absence of kinase or phosphatase. AP treatment resulted in a small but significant increase in Fmax in failing cells (Fig. 6c). In donor cells (Fig. 6d) no effect on Fmax was observed. PKCalpha applied after AP treatment did not affect Fmax in both groups. AP also caused a significant increase in Fpas in both failing and donor cells (Fig. 6e, f), but subsequent PKCalpha treatment failed to restore the original levels.Fig. 6The effects of PKCalpha after dephosphorylation of cTnT by alkaline phosphatase (AP) in failing (n = 5) and donor (n = 4) tissue. Ca2+ sensitivity of force was increased after AP treatment and was subsequently reduced after PKCalpha treatment to the levels observed without AP pretreatment (a, b). AP treatment resulted in a minor but significant increase in maximum force (Fmax) in failing tissue while in donor tissue no change was observed (c, d). Subsequent treatment with PKCalpha had no effect on Fmax. Passive force (Fpas) (e, f) was increased after AP in failing and donor tissue and remained elevated after PKCalpha treatment. *P < 0.05, before versus after phosphatase/kinase treatment in Bonferroni post hoc test
###end p 43
###begin p 44
###xml 97 98 93 94 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 115 116 111 112 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 132 134 128 130 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 291 292 283 284 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 294 295 286 287 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 374 375 366 367 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 375 378 367 370 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 444 445 436 437 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 447 448 439 440 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 503 504 491 492 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 504 507 492 495 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 524 525 512 513 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 525 528 513 516 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pas</sub>
###xml 531 532 519 520 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 534 535 522 523 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 637 638 621 622 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
The effects of PKCalpha after dephosphorylation of cTnT by alkaline phosphatase (AP) in failing (n = 5) and donor (n = 4) tissue. Ca2+ sensitivity of force was increased after AP treatment and was subsequently reduced after PKCalpha treatment to the levels observed without AP pretreatment (a, b). AP treatment resulted in a minor but significant increase in maximum force (Fmax) in failing tissue while in donor tissue no change was observed (c, d). Subsequent treatment with PKCalpha had no effect on Fmax. Passive force (Fpas) (e, f) was increased after AP in failing and donor tissue and remained elevated after PKCalpha treatment. *P < 0.05, before versus after phosphatase/kinase treatment in Bonferroni post hoc test
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 113 115 113 115 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 490 492 490 492 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 634 636 634 636 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 685 687 685 687 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 736 737 736 737 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 739 740 739 740 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 152 157 <span type="species:ncbi:9606">human</span>
This study shows that PKC-mediated phosphorylation of cMyBP-C and cTnI as well as of cTnT cause a reduction of Ca2+ sensitivity of force development in human myocardium. No effects on maximal force generating capacity of the myofilaments were observed, neither upon direct PKC treatment nor following phosphatase pretreatment. On the basis of these data we propose that increased PKC activity in failing myocardium may depress systolic function of the heart as for the same intracellular Ca2+ concentration, the myofilament force generation and thereby developed pressure will be reduced. On the other hand, the reduced myofilament Ca2+ sensitivity may help myocardial relaxation as Ca2+ concentrations are increased in failing hearts [3, 9].
###end p 46
###begin title 47
###xml 71 73 61 63 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
PKCalpha and PKCepsilon phosphorylation of cTnI and cMyBP-C decrease Ca2+ sensitivity in failing myocardium
###end title 47
###begin p 48
###xml 146 148 136 138 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 167 168 157 158 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
Direct incubation of the cardiomyocytes from failing hearts with saturating amounts of active PKCalpha and PKCepsilon resulted in a decrease in Ca2+ sensitivity (Fig. 1). PKCalpha and PKCepsilon incubations of failing tissue resulted in increased phosphorylation of cMyBP-C and cTnI. PKCalpha incubation resulted in higher phosphorylation of cTnI and PKCepsilon in higher phosphorylation levels of cMyBP-C, indicating isozyme specific substrate affinity. Although phosphorylation effects were diverse, the functional consequences of both PKC isoforms were quite similar.
###end p 48
###begin p 49
###xml 82 84 82 84 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 86 88 86 88 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">40</xref>
###xml 218 220 218 220 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 320 322 320 322 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
It has previously been determined that cMyBP-C has PKC-phosphorylatable residues [24, 40]. However, so far no data has been published (to our knowledge) that directly link cMyBP-C phosphorylation with alterations in Ca2+ sensitivity. Our data suggest involvement of PKC-mediated cMyBP-C phosphorylation in the reduced Ca2+ sensitivity observed in failing tissue.
###end p 49
###begin p 50
###xml 18 20 18 20 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 228 230 222 224 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 490 492 464 466 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 824 826 778 780 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
###xml 849 854 <span type="species:ncbi:10090">mouse</span>
###xml 1043 1047 <span type="species:ncbi:10090">mice</span>
###xml 1056 1061 <span type="species:ncbi:9606">human</span>
Kobayashi et al. [20] indicated that PKCepsilon was able to phosphorylate PKA sites on mouse cTnI. Our previous study also showed that the active catalytic domain of PKC caused cross-phosphorylation of the PKA sites (Ser23/24) [35]. We addressed this issue for PKCalpha- and PKCepsilon-mediated phosphorylation by performing experiments where incubations of PKCalpha or PKCepsilon were followed by PKA as well as by incubations in the reverse order. The results showed that the shifts in Ca2+ sensitivity in failing myocardium did not depend on the sequence of application of PKA and PKCalpha/epsilon. This indicates that the effects of the PKC isoforms and PKA were independent and that the PKCalpha/epsilon-mediated effects were not caused by cross-phosphorylation of the PKA sites under our conditions. Kobayashi et al. [20] used the recombinant mouse cTnI and an excess of PKCepsilon, therefore it is possible that the cross-phosphorylation they observed does not occur under more physiological conditions or that it is more pronounced in mice than in human cTn.
###end p 50
###begin title 51
###xml 21 23 17 19 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
PKCalpha decreases Ca2+ sensitivity via cTnT phosphorylation
###end title 51
###begin p 52
###xml 63 65 59 61 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 84 85 80 81 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 210 211 202 203 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 479 480 467 468 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 521 523 505 507 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 584 585 568 569 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
Direct incubation of donor cells with PKCalpha did not alter Ca2+ sensitivity (Fig. 4b), which is in line with minor effects of PKCalpha on protein phosphorylation of cMyBP-C, desmin, cTnI, cTnT and MLC2 (Fig. 4c). The absence of functional effects of PKCalpha is most likely explained by the relatively high baseline phosphorylation status of cMyBP-C, cTnI and cTnT in donor myocardium. Because endogenous cMyBP-C and cTnI phosphorylation levels in donor tissue were high (Fig. 4a) and no major effects of PKCalpha on Ca2+ sensitivity and protein phosphorylation were observed (Fig. 4b, c), the donor tissue was used as a tool to reveal functional effects of PKCalpha-mediated phosphorylation of cTnT.
###end p 52
###begin p 53
###xml 367 369 355 357 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 566 568 550 552 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
AP treatment resulted in a massive decrease in cTnT phosphorylation in failing and donor myocardium. Subsequent treatment with PKCalpha solely increased phosphorylation of cTnT in donor myocardium, which made it possible to identify the role of cTnT upon phosphorylation by PKCalpha. Treatment with PKCalpha following AP treatment showed a significant reduction in Ca2+ sensitivity in both failing and donor tissue. These results indicate that AP is able to dephosphorylate sites on cTnT, which are subsequently targeted by PKCalpha and when phosphorylated reduce Ca2+ sensitivity.
###end p 53
###begin p 54
###xml 68 70 68 70 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 72 74 72 74 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 76 78 76 78 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">40</xref>
###xml 165 167 155 157 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 398 400 388 390 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 453 455 443 445 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 457 459 447 449 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 685 687 675 677 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 865 866 855 856 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 868 870 858 860 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">39</xref>
###xml 1036 1038 1026 1028 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1052 1054 1042 1044 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 522 527 <span type="species:ncbi:9606">human</span>
Overall, our results are in agreement with previous animal studies [17, 24, 40] indicating that functionally relevant targets of PKCalpha- and PKCepsilon-mediated Ca2+ desensitization of the myofilaments are located on cardiac troponin. Both cTnI and cTnT contain a number of different PKC-phosphorylatable sites. On the basis of biochemical in vitro studies Ser-42 and Ser-44 and Thr-143 on cTnI [30] and Thr-194, Ser-198, Thr-203 and Thr-284 on cTnT [17, 34] are considered the main sites (phosphorylated sites based on human sequence). It has been proposed that the relative balance of phosphorylation of the three PKC sites on cTnI is important for the regulation of its function [32]. Pseudophosphorylation of Ser-42/Ser-44 significantly reduced the myofilament response to calcium and phosphorylation of Thr-143 induced an increase in sensitivity to calcium [7, 39]. Among the four phosphorylation sites on cTnT, Thr-203 appeared to be the most important for modulation of cTn function in that it inhibited force as well as its Ca2+ sensitivity [33].
###end p 54
###begin title 55
PKCalpha reduces passive force, but not maximal force
###end title 55
###begin p 56
###xml 145 146 145 146 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 148 150 148 150 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 152 154 152 154 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 156 158 156 158 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 262 263 262 263 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 639 640 635 636 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 640 643 636 639 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 727 729 723 725 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR42">42</xref>
###xml 935 936 927 928 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 936 939 928 931 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 996 998 988 990 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 1129 1131 1121 1123 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 1398 1399 1382 1383 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1399 1402 1383 1386 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 1617 1618 1597 1598 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1618 1621 1598 1601 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 248 253 <span type="species:ncbi:9606">human</span>
###xml 466 471 <span type="species:ncbi:9606">human</span>
###xml 647 652 <span type="species:ncbi:9606">human</span>
###xml 791 796 <span type="species:ncbi:9606">human</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 1087 1092 <span type="species:ncbi:9606">human</span>
###xml 1209 1214 <span type="species:ncbi:9606">human</span>
###xml 1635 1640 <span type="species:ncbi:9606">human</span>
Rodent studies indicate that PKC-mediated phosphorylation results in a reduction of the maximum force generating capacity of the cardiomyocytes [8, 26, 32, 33]. A study using an in vitro motility assay suggested that this might also be the case in human tissue [2]. However, the present results did not show depression of force upon PKC treatment and indicate that caution should be exerted when extrapolating data obtained in rodent studies to force development in human cardiomyocytes. Cardiac cTnI and cTnT phosphorylation by PKC may occur at different sites in different species and may explain the absence of an effect of PKCalpha on Fmax in human cardiomyocytes. Only recently, using mass spectrometry Zabrouskov et al. [42] revealed a novel phosphorylation site (Ser-76 or Thr-77) in human cTnI, while no phosphorylation was observed at the sites mentioned above. A study in mice revealed that the PKCalpha-induced reduction in Fmax critically depended on cTnT phosphorylation at Thr-203 [33]. Future studies should be performed to reveal which sites are phosphorylated by PKC in human myocardium. Recently Molnar et al. [25] showed that PKCalpha contributes to the maintenance of contractile force in human cardiomyocytes, which is in line with our results that PKCalpha treatment does not negatively affect maximal force. AP treatment resulted in a small (~5%) but significant increase in Fmax. However, subsequent treatment with PKCalpha did not result in a reduction of force development. This suggests that AP is able to dephosphorylate at least to some extent one of the contractile proteins determining Fmax. However, in human tissue the impact is rather small and the link with PKCalpha is not evident.
###end p 56
###begin p 57
###xml 52 53 48 49 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 53 56 49 52 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pas</sub>
###xml 183 184 173 174 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 233 234 223 224 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 234 237 224 227 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pas</sub>
###xml 562 563 544 545 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 565 567 547 549 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 569 571 551 553 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">41</xref>
###xml 807 808 781 782 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1275 1277 1241 1243 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
PKCalpha treatment resulted in a small reduction of Fpas both in donor and in failing cardiomyocytes, whereas PKCepsilon had no significant effect but did show a similar trend (Table 2). AP treatment caused a significant increase in Fpas in both failing and donor cells but subsequent PKCalpha treatment did not restore the original levels. These results suggest that the effects of PKCalpha-mediated phosphorylation and AP-induced dephosphorylation on stiffness are independent, and indicate that at least two distinct phosphorylation sites, possibly on titin [4, 22, 41], are involved in the modulation of passive stiffness of the cardiomyocytes. To address this issue, the effect of PKCalpha in titin phosphorylation after incubation with PKCalpha was investigated both in donor and failing tissue (Fig. 2). However, no significant effect was observed. This could imply that phosphorylation of titin is not solely responsible for the decrease in passive force observed after PKCalpha. However, since titin may contain numerous phosphorylation sites with one or few PKCalpha dependent sites, it might be that our method is not sensitive enough to resolve the minor relative changes in titin phosphorylation as appeared to be the case for protein kinase G by Kruger et al. [21].
###end p 57
###begin p 58
###xml 8 9 8 9 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 9 12 9 12 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pas</sub>
###xml 123 124 123 124 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
As high Fpas has been associated with high left ventricular end-diastolic pressure in patients with diastolic dysfunction [4], the reduction in passive stiffness by PKCalpha-mediated phosphorylation might improve diastolic filling of the heart.
###end p 58
###begin title 59
Limitations and conclusions
###end title 59
###begin p 60
In this study the effects of the kinases and phosphatases on the phosphorylation levels are represented relative to basal phosphorylation levels for each protein. Although the changes in protein phosphorylation levels were relatively small, the functional changes were significant and may be physiologically relevant.
###end p 60
###begin p 61
###xml 100 101 96 97 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 807 809 796 798 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 1270 1275 <span type="species:ncbi:9606">human</span>
Since the transition to end-stage heart failure is accompanied by an increase in PKCalpha activity [6] it is surprising that the effects of PKCalpha are observed only in end-stage failing hearts and become visible in donor hearts only after dephosphorylation by alkaline phosphatase. It should be noted, however, that the endogenous phosphorylation levels in the explanted myocardium studied not necessarily reflect the in vivo situation. The lower levels of cMyBP-C and cTnI phosphorylation observed in end-stage failing compared to donor myocardium may reflect desensitisation of the beta-adrenergic pathway. Moreover, it has been suggested that high catecholamine levels at the time of tissue procurement underlies the relative high levels of cMyBP-C and cTnI phosphorylation levels in donor myocardium [23]. Future studies in biopsy samples taken under well-controlled hemodynamic conditions with parallel measurements of blood catecholamines should be performed to address this issue. Nevertheless, the data presented in this study clearly indicate that changes in expression and activation of PKCalpha and PKCepsilon in response to pathophysiological stressors or increased hemodynamic demands during exercise translate into alterations in contractile function in human myocardium.
###end p 61
###begin title 62
Open Access
###end title 62
###begin p 63
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 63
###begin title 64
References
###end title 64
###begin article-title 65
Alterations in protein kinase C isoenzyme expression and autophosphorylation during the progression of pressure overload-induced left ventricular hypertrophy
###end article-title 65
###begin article-title 66
Augmented Protein Kinase C-alpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure
###end article-title 66
###begin article-title 67
###xml 39 42 <span type="species:ncbi:10116">rat</span>
Slow contractions characterize failing rat hearts
###end article-title 67
###begin article-title 68
Cardiomyocyte stiffness in diastolic heart failure
###end article-title 68
###begin article-title 69
###xml 99 104 <span type="species:ncbi:9606">human</span>
Hypophosphorylation of the stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium
###end article-title 69
###begin article-title 70
###xml 56 58 56 58 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 93 98 <span type="species:ncbi:9606">human</span>
Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart
###end article-title 70
###begin article-title 71
PKC-alpha regulates cardiac contractility and propensity toward heart failure
###end article-title 71
###begin article-title 72
Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity
###end article-title 72
###begin article-title 73
Defects in calcium control
###end article-title 73
###begin article-title 74
Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation
###end article-title 74
###begin article-title 75
Protein kinase C epsilon overexpression alters myofilament properties and composition during the progression of heart failure
###end article-title 75
###begin article-title 76
Protein kinase C alpha negatively regulates systolic and diastolic function in pathological hypertrophy
###end article-title 76
###begin article-title 77
Pharmacological- and gene therapy-based inhibition of protein kinase C alpha/beta enhances cardiac contractility and attenuates heart failure
###end article-title 77
###begin article-title 78
Sarcomeric dysfunction in heart failure
###end article-title 78
###begin article-title 79
Arachidonic acid stimulated protein kinase C-epsilon resdistribution in heart cells
###end article-title 79
###begin article-title 80
Myofilament anchoring of protein kinase C-epsilon in cardiac myocytes
###end article-title 80
###begin article-title 81
###xml 63 69 <span type="species:ncbi:9913">bovine</span>
Phosphorylation specificities of protein kinase C isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties
###end article-title 81
###begin article-title 82
Calcium, thin filaments, and the integrative biology of cardiac contractility
###end article-title 82
###begin article-title 83
###xml 77 80 <span type="species:ncbi:10116">rat</span>
Protein kinase C isozymes in hypertension and hypertrophy: insight from SHHF rat hearts
###end article-title 83
###begin article-title 84
A non-equilibrium isoelectric focusing method to determine states of phosphorylation of cardiac troponin I: identification of Ser-23 and Ser-24 as significant sites of phosphorylation by protein kinase C
###end article-title 84
###begin article-title 85
###xml 27 32 <span type="species:ncbi:9606">human</span>
Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs
###end article-title 85
###begin article-title 86
Sense and stretchiability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction
###end article-title 86
###begin article-title 87
###xml 43 45 43 45 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Troponin phosphorylation and myofilament Ca2+- sensitivity in heart failure: Increased or decreased?
###end article-title 87
###begin article-title 88
Cardiac myosin-binding protein C (MyBP-C): identification of protein kinase A and protein kinase C phosphorylation sites
###end article-title 88
###begin article-title 89
###xml 72 77 <span type="species:ncbi:9606">human</span>
Protein kinase C contributes to the maintenance of contractile force in human ventricular cardiomyocytes
###end article-title 89
###begin article-title 90
Transgenic incorporation of skeletal TnT into cardiac myofilaments blunts PKC-mediated depression of force
###end article-title 90
###begin article-title 91
###xml 18 23 <span type="species:ncbi:9606">human</span>
Skinned fibers of human atrium and ventricle: myosin isozymes and contractility
###end article-title 91
###begin article-title 92
###xml 108 113 <span type="species:ncbi:9606">human</span>
Impaired diastolic function after exchange of endogenous troponin I with C-terminal truncated troponin I in human cardiac muscle
###end article-title 92
###begin article-title 93
###xml 61 66 <span type="species:ncbi:9606">human</span>
Thin filament-based modulation of contractile performance in human heart failure
###end article-title 93
###begin article-title 94
###xml 42 48 <span type="species:ncbi:9913">bovine</span>
Identification of sites phosphorylated in bovine cardiac troponin I and troponin T by protein kinase C and comparative substrate activity of synthetic peptides containing the phosphorylation sites
###end article-title 94
###begin article-title 95
Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase1
###end article-title 95
###begin article-title 96
The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation
###end article-title 96
###begin article-title 97
Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T
###end article-title 97
###begin article-title 98
###xml 24 30 <span type="species:ncbi:9913">bovine</span>
Sites phosphorylated in bovine cardiac troponin T and I. Characterization by 31P-NMR spectroscopy and phosphorylation by protein kinases
###end article-title 98
###begin article-title 99
###xml 79 84 <span type="species:ncbi:9606">human</span>
Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium
###end article-title 99
###begin article-title 100
###xml 58 60 58 60 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 105 110 <span type="species:ncbi:9606">human</span>
The effect of myosin light chain 2 dephosphorylation on Ca2+-sensitivity of force is enhanced in failing human hearts
###end article-title 100
###begin article-title 101
###xml 12 14 12 14 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 69 74 <span type="species:ncbi:9606">human</span>
Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins
###end article-title 101
###begin article-title 102
###xml 85 88 <span type="species:ncbi:10116">rat</span>
Effects of contractile protein phosphorylation on force development in permeabilized rat cardiac myocytes
###end article-title 102
###begin article-title 103
###xml 48 50 48 50 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
PKC-betaII sensitizes cardiac myofilaments to Ca2+ by phosphorylating troponin I on threonine-144
###end article-title 103
###begin article-title 104
PKCepsilon increases phosphorylation of the cardiac myosin binding protein C at serine 302 both in vitro and in vivo
###end article-title 104
###begin article-title 105
###xml 99 102 <span type="species:ncbi:10116">rat</span>
Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes
###end article-title 105
###begin article-title 106
###xml 50 55 <span type="species:ncbi:9606">human</span>
Unraveling molecular complexity of phosphorylated human cardiac troponin I by top down electron capture dissociation/electron transfer dissociation mass spectrometry
###end article-title 106
###begin article-title 107
Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies
###end article-title 107

